• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Cardiostim 2012 Advance Program
 

Cardiostim 2012 Advance Program

on

  • 2,318 views

 

Statistics

Views

Total Views
2,318
Views on SlideShare
2,318
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Cardiostim 2012 Advance Program Cardiostim 2012 Advance Program Document Transcript

    • CARDIOSTIM 2010A dva n ce p rogra m 18th World Congress in Cardiac Electrophysiology & C a r d i a c Te c h n i q u e s June 13 > 16 I 2012 Nice • FrAncE Painting by Françoise Persil­­­­lon Advance program www.cardiostim.com In collaboration with www.cardiostim.fr 1
    • Cardiostim 2012 éditorialEuropean Heart Rhythm Association (EHRA) Program A messageWednesday June 13 / 00:00 AM Wednesday June 13 / 00:00 AM from the Chairman of CardiostimCARDIAC STEM CELLS AND GENE THERAPY NEW IMAGING TECHNIQUESChair: Chair:Cohen I. - Stony Brook, USA Kalman J. - Melbourne, AUSFast V. - Birmingham, USA Mazgalev T.N. - Cleveland, USA•  aking Hearts Regenerate M •  lectrocardiographic Imaging to Understand Arrhythmia EDear Colleagues, DearCHE Pedrazzini T. - Lausanne, Friends, Mechanisms•  ardiac Differentiation of Human Keratinocytes Derived from C Rudy Y. - St. Louis, USAToday is already tomorrow! Plucked Hair Follicles •  imulations to Predict Sites of VT Ablation S Trayanova N. A. - come. AdvancesIn Binah O. - were announcing revolutions in the Electrophysiology world for the years to Baltimore, USA are now on the way, and 2010, we Haifa, ISR •  RI for Risk Prediction of Arrhythmogenic Areas Mtheir first applications Stem Cells from Patients the 2012 edition of Cardiostim!• nduced Pluripotent will be discussed during with Inherited I Halperin H. - saved by USARoutine ablation procedures for VT/VF, especially during electrical storms in patientsBaltimore, their ICD, robotic and 3D mapping Arrhythmiasand navigation - Madison, USA •  hat Are the Clinical Implications? management, transeptal, W new anticoagulants in AF January C. T. for EP and ablation techniques, contact force control,pericardialthe robotic approaches to the left ventricle for CRT, cardiac simulation - Mannheim, DEU arrhythmia mechanisms and•  hat Are or Clinical Implications? W Borggrefe M. for understandingCRT, among many others, are some of the major topics that will be introduced Discussion •  eneral and debated! G Rosen M. R. - New York, USANew recommendations on palpitation management and CRT implantation and follow-up will be presented. Formerly recognized• General Discussionindications will be revisited, such as vaso-vagal syncope, hypertrophic cardiomyopathy or Brugada syndrome. Lots ofdebates will be organized as shows and you’ll be able to give your opinion through voting systems in many of the programs settled bythe most famous experts.What is unique in Cardiostim is the atmosphere that brings more and more people to this friendly meeting whereattendees can freely express their opinion.That is probably why, despite the international financial crisis, more than a thousand abstracts have been received from all over theworld, and especially from countries that were not present until now in our congress, demonstrating the interest of colleagues keen tocome to Nice to present their data and debate! Congratulations to all authors for their scientific contribution.The EHRA Program Committee members, conducted by Andreas Goette (Leipzig – Germany), participated actively in the abstractselection in addition to the Cardiostim members. Consequently, each abstract has been reviewed by at least 6 experts. The SelectionCommittee rejected 43 % abstracts overall. This year, a smaller number of oral abstract sessions is proposed to enhance the qualityof the presented material. I must congratulate and thank everyone for these difficult tasks!As can be seen along this Advance Program, the global result of the combination of EHRA sessions with the traditional programsproposed by our American friends and the Cardiostim Team is a high standard program that one will remind as the most completeand attractive ever!Our task is to translate this knowledge into understandable and useful information for clinical practice. This is whyCardiostim also proposes educational sessions based on case presentations in the general program as well as dedicated sessions.With the same logics, specific sessions will be dedicated to technicians and nurses.Next June, you will enjoy Cardiostim! The platform to consult and free download ECG and Epidemiology data Philippe Ritter - Chairman http://epdatabank.cardiostim.com www.cardiostim.com 3
    • springermedizin.de Up-to-date – Qualified – Online Clinical Research in Cardiology • Current and competent survey on the diagnosis and therapy of heart and vascular diseases • Impact Factor 2010: 3.466, rank 31/114 (Journal Citation Reports ® Thomson Reuters) • Official Journal of the German Cardiac Society www.crc.springer.de Extensive online archive! 050357
    • Cardiostim 2012Congress Highlights in 2012THE EHRA PROGRAM An extensive program was designed by the Scientific Program Committee of EHRA, and will include a total number of 30 sessions.HIGH-TECH ADVANCES Among many others, four sessions will focus on new technologies that will impact our practice in the future with the following topics: understanding of arrhythmia mechanisms and signal processing, computer simulation in electrophysiology and CRT.HIGH STANDARD EDUCATION Educational material is proposed in all programs, based on Case presentations. In the EP and ablation section, a specific program is proposed by George Klein on Saturday June 16. In addition a Program is given in French on devices, and two sessions are dedicated to technicians and nurses.EPDatabank by cardiostim New in Cardiostim! Educational material is available on http://epdatabank.cardiostim.com for your own purposes. Epidemiologic information, ECG tracings, EGMs, etc… can be downloaded for free! Don’t hesitate to submit yours! The platform to consult and free download ECG and Epidemiology data http://epdatabank.cardiostim.com www.cardiostim.com 5
    • Advance programScientific Organizing CommitteeCARDIOSTIM TEAMPhilippe Ritter (Bordeaux, FRA)Pierre Bordachar, Stéphane Garrigue, Sylvain Reuter, Frédéric Sacher (Bordeaux, FRA), Mark O’Neill (London, GBR),Vincent Probst (Nantes, FRA)David Hayes (Rochester, USA) J.Claude Daubert (Rennes, FRA)Douglas Zipes (Indianapolis, USA) J.Jacques Blanc (Brest, FRA)European Heart Rhythm Association (EHRA)President: Angelo Auricchio (Lugano, CHE)Europace 2013 Program Committee Chairman: Andreas Götte (Magdeburg, DEU)Vice-Chairman: John M. Morgan (Southampton, GBR)Preparation Committee for Scientific ProgramsTo date, will be implemented as we go alongAbi-Samra F. M. USA Butter C. DEU Dobrev D. DEU Gorenek B. TURAdragao P. PRT Calkins H. USA Dodinot B. FRA Gras D. FRAAliot E. FRA Callans D. USA Dolan B. USA Grunnet M. DNKAllessie M. NLD Camm A. J. GBR Dorian P. CAN Guiraudon G. M. CANAlonso C. FRA Cannom D. S. USA Dubner S. ARG Guirgis M. FRAAmman P CHE Cappato R. ITA Duffy H. USA Gulizia M. ITAAntzelevitch C. USA Capucci A. ITA Duytschaever M. BEL Hachiya H. JPNArnar D ICE Carlson M. D. USA Efimov I. R. USA Haigney M. USAAsirvatham S. J. USA Cazeau S. FRA Ehrlich J. DEU Haines D. E. USAAtie J. BRA Cha Y. M. USA Ellenbogen K. USA Haïssaguerre M. FRAAtienza F. ESP Chen S. A. TWN El-Sherif N. USA Halimi F FRAAuricchio A. CHE Cheng J. USA Epstein L. USA Hammill S. C. USABadhwar N. USA Chirife R. ARG Erdogan A. DEU Hasin Y. ISRBehrenbeck T. USA Clemmensen P.M. DNK Ernst S. DEU Hastrup Svendse J DNKBelott P. H. USA Cohen I. USA Exner D. CAN Hatala R. CZEBenditt D. G. USA Cooke D. USA Ezekowitz M. D. USA Hayes D. USABerenfeld O. USA Coronel R. NLD Fast V. USA Healey J. S. USABiffi M. ITA Corrado D. ITA Fedorov V. USA Heidbüchel H. BELBinner L. DEU Cowie M. GBR Fermont L. FRA Helland J. USABlanc J. J. FRA Crijns H. J. NLD Fernandez Lozano I. ESP Hill M. USABlomström-Lundqvist C. WE S Curnis A. ITA Fishman G. I. USA Hindricks G. DEUBoersma L. NLD Danchin N. FRA Flammang D. FRA Hirao K. JPNBongiorni M. G. ITA Darrel F. GBR Franz M. USA Ho I. USABordachar P. FRA Daubert J. C. FRA Friedman P. A. USA Hocini M. FRABorggrefe M. DEU Davies W. GBR Furniss S. GBR Hoffmann E. DEUBoriani G. ITA Davy J. M. FRA Gaita F. ITA Hohnloser S. DEUBotto G. ITA De Chillou C. FRA Gammage M. GBR Hombach V. DEUBoveda S. FRA De Roy L. BEL Garrigue S. FRA Hornberger L. K. USABoyden P. A. USA Deaton C GBR Geelen P. BEL Husser D DEUBrachmann J DEU Defaye P. FRA Geller C. DEU Iacopino S. ITABraunschweig F. SWE Deharo J. C. FRA Gerstenfeld E. USA Ideker R. E. USABreithardt G. DEU Della Bella P. ITA Gilmour R. USA Ishikawa T. JPNBrignole M. ITA Delnoy P. P. NLD Giudici M. USA Israel C. W. DEUBrugada P. BEL Dickstein K. NOR Goette A. DEU Jackman W. M. USABurri H. CHE Diener H. C. DEU Gold M. USA Jahangir A. USA6 www.cardiostim.com
    • Cardiostim 2012Jaïs P. FRA McGann C. USA Rhode K. GBR Sternick E. BRAJalife J. USA McKenna W. J. GBR Ricci R. ITA Stevenson W. G. USAJanse M. NLD McVenes R. USA Rich M. USA Sticherling C. CHEJansens J. L. BEL Meine M. NLD Rinaldi A. ITA Stone P. H. USAJauvert G. FRA Meinertz T. DEU Rizzo G. ITA Stotts L. USAJordaens L. NLD Mohr F. W. DEU Roberts P. GBR Suga C. JPNJung W DEU Molina L. MEX Roden D. M. USA Sulke N. USAKaab S. DEU Mont L. ESP Rodriguez E. ESP Sutton R. MCOKacet S. FRA Moorman A. NLD Roguin A. ISR Svendsen J. H. DNKKalifa J. USA Morgan J. M. GBR Rohr S. CHE Szili-Török T. NLDKalman J. M. AUS Morillo C. CAN Ronaszéki A. HUN Taborsky M. CZEKautzner J. CZE Moss A. J. USA Rosen M. R. USA Tanel R. USAKay N. USA Munger T. T. USA Rosenbaum D. S. USA Thambo J. B. FRAKeane D. USA Murgatroyd F. D. GBR Rowland E. GBR Thermistocles S. ITAKennergren C. SWE Myerburg R. J. USA Rozkovec A. DEU Thibault B. CANKenny R. A. IRL Naccarelli G. V. USA Rudy Y. USA Thiene G. ITAKirchhof P. DEU Nademanee K. USA Ruffy R. USA Thijs V. BELKleber A. CHE Nakagawa H. USA Ruiz-Granell R. ESP Tomaselli G. F. USAKlein G. J. CAN Nakazato Y. JPN Ruskin J. N. USA Tondo C. ITAKlein H. DEU Nanthakumar K. CAN Sacher F. FRA Trayanova N. USAKlingenheben T. DEU Narayan S. M. USA Sadoul N. FRA Treede H. DEUKlug D. FRA Natale A. USA Saffitz J. E. USA Tristani-Firouzi M. USAKnecht S. BEL Nattel S. CAN Saghy L HUN Tse H. F. CHNKnight B. USA Nerbonne J. USA Saksena S. USA Tseng G. N. USAKottkamp H. DEU Neumann T. DEU Salama G. USA Tubaro M. ITAKrieger D. DNK Neuzil P. CZE Sanders P. FRA Turitto G. USAKrueger M. DEU Nielsen J. C. DNK Sanguinetti M. USA Valiunas V. USAKuck K. H. DEU Nogami A. JPN Santini M. ITA van Gelder I. C. NLDKusumoto F. USA Norihisa T. JPN Santomauro M. ITA Van Gelder B. NLDLa Rovere M. T. ITA Olgin J. USA Savelieva I. GBR Van Wagoner D. R. USALakatta E. USA Olshansky B. USA Saxon L. USA Vardas P. E. GRCLau C. P. CHN O’Neill M. GBR Schaerf R. USA Varma N. USALazarus A. FRA Opthof T. NLD Schalij M. NLD Verrier R. L. CANLazzara R. USA Oseroff O. ARG Scheinman M. USA Vesin J. M. CHELe Heuzey J. Y. FRA Oto A. TUR Schilling R. DEU Viskin S. ISRLeclercq C. FRA Ovsyshcher E. ISR Schleich J. M. FRA Vlietstra R. USALeclercq J-F FRA Oyarzun R CHL Schmidt B. DEU Vogt J. DEULee H. C. USA Packer D. L. USA Schmidt G. DEU Vohra J. K. AUSLeenhardt A. FRA Padeletti L. ITA Schotten U. NLD Vos M. NLDLévy S. FRA Page R. L. USA Schuger C. USA Vrints C. BELLewalter T. DEU Panfilov A. V. NLD Schumacher B. DEU Waldo A. L. USALickfett L. DEU Pappone C. ITA Schwartz P. J. ITA Wallentin L. DEULinde C. M. SWE Parkhomenko A. UKR Schweikert R. USA Weiss J. USALinker N. J. GBR Parry S. W. GBR Schwitter J. CHE Wellens H. J. NLDLip GYH GBR Pedretti R. ITA Semisarian C. AUS Wieling W. NLDLocati E. ITA Pelleg A. USA Sermasant M. FRA Wilber D. J. USALoh P. NDL Piccini J. USA Sethi K. IND Wilde A. M. NLDLondon B. USA Piorkowski C. DEU Shah D. CHE Wilkoff B. L. USALove C. J. USA Poelzing S. DEU Shaw R. USA Willems S. DEULubinski A. POL Pokushalov E RUS Shen W. USA Wolpert C. DEUMabo P. FRA Poole J. E. USA Shivkumar K. USA Xhaet O. FRAMaier L. DEU Pratt C. M. USA Shoda M. JPN Yamada K. USAMalik M. GBR Prinzen F. W. NLD Simantirakis E. N. GRC Yamane T. JPNManolis A. S. GRC Priori S. G. ITA Siu D. CHN Yang Y. USAMansour M. USA Pruvot E. CHE Sloman G. AUS Yu C. M. CHNMantovan R. ITA Prystowsky E. N. USA Smith N. GBR Zannad F. FRAMarcus F. USA Puererfellner H. AUT Sogaard P. DNK Zareba W. USAMarkijarvi M. FIN Quinn T. GBR Sommer T. DEU Zaza A. ITAMaron B. USA Rasmussen L. H. DNK Sperzel J. DEU Zeppenfeld K. NLDMarrouche N. F. USA Raviele A. ITA Squarcia U. ITA Zieman S. USAMartinek M. AUT Rea R. USA Steinbeck G. DEU Zipes D.P. USAMazgalev T. N. USA Reddy V. Y. USA Steinberg J. USA Zupan I. SVNMcCarty J. USA Revishvilli A. RUS Steinhaus D. USAMcElderry T. USA Reynolds D. W. USA Stern S. ISR www.cardiostim.com 7
    • Advance programIn collaboration with• European Heart Rhythm Association (EHRA)• Société Française de Cardiologie• European Society of Cardiology• Heart Rhythm Society (HRS)• World Society of Arrhythmias WSA/ICPES• International Society for Holter and Noninvasive Electrocardiology (ISHNE)• Groupe Français d’Electrophysiologie et de Stimulation Cardiaque de la Société Française de Cardiologie• Sociedad Asociación Civil Argentina de Estimulación Cardiaca (SADEC)• Asian-Pacific Society of Cardiology• Brazilian Society of Cardiology• Latin-American Society of Pacing and Electrophysiology (SOLAECE)• Artificial Cardiac Electrostimulation Department of the Brazilian Cardiac Surgery Group (DECA)• Associazione Italiana di Aritmologia e Cardiostimolazione (AIAC)• Mediterranean Society of Pacing and Electrophysiology (MESPE)•  he RETAC Group (Reunion of European countries for the Treatment of Arrhythmias in Cardiology/Réseau Européen T pour le Traitement des Arythmies Cardiaques)CME ACCREDITATIONEHRA SESSIONS at CARDIOSTIM 2012 are currently under review for accreditation by the European Boardfor Accreditation in Cardiology (EBAC) for external CME credits.The accreditation results will be announced online and in the final program. Subscribe to Cardiostim newsletter ✓ on www.cardiostim.com8 www.cardiostim.com
    • Cardiostim 2012ContentsEuropean Heart Rhythm Association (EHRA) Program.............................................................................................. P. 10Basic Electrophysiology.............................................................................................................................................. P. 19Complex Electrophysiology and Ablation Techniques.............................................................................................. P. 23• Novel Approaches to Apply Mechanistic Insights to Complex Human ArrhythmiasTreatments for Atrial Fibrillation................................................................................................................................. P. 29• Advances and Controversies in Atrial Fibrillation (ACAF)Noninvasive Electrocardiology.................................................................................................................................... P. 30• Educational Symposium of International Society for Holter and Noninvasive Electrocardiology (ISHNE)Main Trials in the Management of Atrial Fibrillation.................................................................................................. P. 34Acute Cardiac Care: Management of SCD.................................................................................................................. P. 35Pacing, ICDs and CRT.................................................................................................................................................. P. 36Leads............................................................................................................................................................................ P. 43Associate Symposia.................................................................................................................................................... P. 45• Cardiostim / HRS Joint Session• Cardiopace• Vaso Vagal Syncope• Geriatric Cardiology• Asia Pacific Cardiostim Symposium• Palpitations• Fetal Cardiology Symposium• Pediatric Cardiac Electrophysiology• Cardiostim-JHRS Joint Session• Syncope• ICE Program• Italian Cardiostim Symposium• EPIC AllianceIndustry Symposia....................................................................................................................................................... P. 53Symposium STIMUPRAT.............................................................................................................................................. P. 59 The publisher and the Cardiostim organization disclaim any liability for errors or omissions that may come to light, despite the care taken in the production of this Advance Program. www.cardiostim.com 9
    • Advance programEuropean Heart Rhythm Association (EHRA) ProgramOrganized bythe Scientific Committee of EHRA,Coordination, Program Committee Andreas Götte - Magdeburg, DEUWednesday June 13 / 9:00 - 10:30 Wednesday June 13 / 9:00 - 10:30CRT IN THE 21ST CENTURY. WHAT DO WE NEW INSIGHTS IN BASICS OF ARRHYTHMIASHAVE NOW? STATUS QUO AND QUO VADIS? Chair:Chair: Crijns H. J. - Maastricht, NLDBoriani G. - Bologna, ITA Savelieva I. - London, GBRKuck K. H. - Hamburg, DEU •  alcium Handling and Arrhythmias: A Link to Be Targeted C•  RT in Ischemic Heart Failure Patients: From Cell Function to C Zaza A. - Milano, ITA Clinical Outcome •  Nodes» in the Arrhythmia Pathogenetic Network « Auricchio A. - Lugano, CHE Schotten U. - Maastricht, NLD•  RT in Patients with Atrial Fibrillation C •  itochondrial Dysfunction and Arrhythmias M Vardas P. E. - Heraklion, GRC O’Rourke B. - Baltimore, USA•  wo Years with New Guidelines. Do We Have Unresolved T •  linical Evidence and Possible Therapy of These Arrhythmias C Questions? Van Gelder I. C. - Groningen, NLD Dickstein K. - Stavanger, NOR•  RT in Narrow QRS C Ponikowski P. - Wroclaw, POLWednesday June 13 / 9:00 - 10:30 Wednesday June 13 / 9:00 - 10:30PACEMAKER THERAPY IN YEAR 2012 ION CHANNELOPATHIESChair: Chair:Simantirakis E. N. - Heraklion, GRC Jalife J. - Ann Arbor, USAOyarzun R. - Santiago, CHL Kaab S. - Munchen, DEU•  ow Important Is Minimization of RV Pacing? H •  ong QT Syndrome - Types and Therapies L Israel C. W. - Bielefeld, DEU Priori S. G. - Pavia, ITA•  R Safe Pacemakers M •  rugada Syndrome - Place of Ion Channel Antiarrhythmic B Davy J. M. - Montpellier, FRA Drugs Wolpert C. - Mannheim, DEU•  here in the RV Should Ventricular Pacing Be Applied? W Butter C. - Bernau, DEU •  Wave Syndromes J Antzelevitch C. - Utica, USA•  hould AAI Pacing Be Considered Obsolete? S Nielsen J. C. - Aarhus, DNK • diopathic Ventricular Fibrillation - Does It Exist? I Wilde A. M. - Amsterdam Zuidoost, NLD10 www.cardiostim.com
    • Cardiostim 2012European Heart Rhythm Association (EHRA) ProgramWednesday June 13 / 11:00 - 12:30 Wednesday June 13 / 11:00 - 12:30CRT: READING THE GUIDELINES WHAT A DEVICE SPECIALIST NEEDS TO KNOWChair: ABOUT HEART FAILUREAuricchio A. - Lugano, CHE Chair:Kirchhof P. - Birmingham, GBR Daubert J. C. - Rennes, FRA Ponikowski P. - Wroclaw, POL•  RT in Mild Heart Failure C Linde C. M. - Stockholm, SWE •  acing in Heart Failure: What Happens on the Cellular Level? P•  RT in Atrial Fibrillation C Vanderheyden M. - Aalst, BEL Sutton R. - Monaco, MCO •  ptimal Medical Treatment in Heart Failure O•  RT in Patients with Conventional Pacemaker Indications C Cowie M. - London, GBR Burri H. - Geneva, CHE •  he Device Patient with End Stage Heart Failure T•  RT in Clinical Practice: The European CRT Survey C Fruhwald F. - Graz, AUT Dickstein K. - Stavanger , NOR •  ole of Implantable Sensors in Heart Failure Management R Braunschweig F. - Stockholm, SWEWednesday June 13 / 11:00 - 12:30PURKINJE FIBERS AND VENTRICULARARRHYTHMIASChair:Kuck K. H. - Hamburg, DEULeclercq J. F. - Levallois, FRA•  rrhythmia of Purkinje Fibers: Specificity of Cellular A Mechanisms Ehrlich J. - Frankfurt, DEU•  ffect of Antiarrhythmic Drugs on the Purkinje Network: E Electrophysiological and Pharmacological Aspects Vos M. - Utrecht, NLD•  blation of Polymorphic VT in Patients with Structural Heart A Disease TBD• diopathic VF Originating from the Purkinje Network: Ablation I Targets and Long-Term Follow-Up Knecht S. - Brussels, BEL www.cardiostim.com 11
    • Advance programEuropean Heart Rhythm Association (EHRA) ProgramWednesday June 13 / 14:00 - 15:30 Wednesday June 13 / 16:00 - 17:30NEW EHRA DOCUMENTS ICD THERAPY IN YEAR 2012Chair: Chair:Raviele A. - Venice, ITA Garrigue S. - Bordeaux, FRA Svendsen J. H. - Copenhagen, DNK•  alpitations P Raviele A. - Venice, ITA •  efibrillation Testing during Implant: To Do or Not to Do? D•  leeding Risk B Baensch D. - Rostock, DEU Lip G. Y. - Birmingham, GBR •  ow to Reduce Inappropriate Shock Therapy H• ICD for Life’ Initiative-Fighting against Sudden Cardiac Death ‘ Wolpert C. - Mannheim, DEU in Emerging Economies. •  eliability of Implantable Devices and Leads - Are They Good R Merkely B. - Budapest, HUN Enough?•  enetic Testing G Steinhaus D. M. - Mounds View, USA Priori S. G. - Pavia, ITA •  ow Should We Program Tachy Parameters in ICDs. H Zupan I. - Ljubljana, SVNWednesday June 13 / 14:00 - 15:30 Wednesday June 13 / 16:00 - 17:30SUDDEN CARDIAC DEATH IN THE YOUNG STATE-OF-THE ART ON VENTRICULARChair: TACHYCARDIA ABLATIONHeidbüchel H. - Leuven, BEL Chair:Morgan J. M. - Southampton, GBR De Chillou C. - Nancy, FRA Wellens H. J. - Maastrisht, NLD•  utopsy Rate and Cause of Death in the Young: A National A Study from Denmark •  ndocardial Catheter Ablation of Monomorphic VT: From E Winkel B. G. - Copenhagen, DNK Bench to EP Lab•  rugada Syndrome: Not as Dangerous as First Assumed? B Atie J. - Rio do Janeiro, BRA Borggrefe M. - Mannheim, DEU •  picardial Approach: A First Line Therapy? E•  ow Should We Make a Work-Up in Young Cardiac Arrest H Della Bella P. - Milano, ITA Survivors? •  ew Mapping and Ablation Strategies for Catheter Ablation of N Braunschweig F. - Stockholm, SWE VT in Patients with Dilated Cardiomyopathies•  oronary Abnormalities and Sudden Cardiac Death C Piorkowski C. - Leipzig, DEU Ho S. Y. - London, GBR •  ombined Ablation Endo-Epicardial Approach for VT Ablation C Kottkamp H. - Zurich, CHE12 www.cardiostim.com
    • Cardiostim 2012European Heart Rhythm Association (EHRA) ProgramThursday June 14 / 09:00 - 10:30 Thursday June 14 / 11:00 - 12:30PREVENTING SUDDEN CARDIAC DEATH WITH HIGHLIGHTS FROM EUROPACE 2011: DEVICERF ABLATION THERAPY, INTERVENTIONAL EP AND MEDICALChair: THERAPYHaïssaguerre M. - Pessac, FRA Chair:Mont L. - Barcelona, ESP Auricchio A. - Lugano, CHE Hindricks G. - Leipzig, DEU•  apping and Ablation of Idiopathic Ventricular Fibrillation M Sacher F. - Bordeaux, FRA • nterventional EP I•  revention of VF Episodes in Brugada Syndrome by Catheter P Merino J. L. - Madrid, ESP Ablation •  harmacotherapy P Merino J. L. - Madrid, ESP Camm A. J. - London, GBR•  ombined Endocardial and Epicardial Ablation in Patients with C •  acing P ARVD Vardas P. E. - Heraklion, GRC Wissner E. - Hamburg, DEU •  efibrillation and CRT-D D•  atheter Ablation of Ventricular Electrical Storms C Wolpert C. - Mannheim, DEU Atie J. - Rio do Janeiro, BRAThursday June 14 / 09:00 - 10:30STROKE PREVENTION IN ATRIAL FIBRILLATION:STATE-OF-THE ART AND NEW CONCEPTSChair:Camm A. J. - London, GBRRasmussen L. H. - Aalborg, DNK•  asic Science Insights into the Prothrombotic State in Atrial B Fibrillation De Caterina R. - Chieti, ITA•  linical Trial Update - What Do the RELY, ROCKET, C ARISTOTLE and AVERROES Trials Tell Us? Lip G. Y. - Birmingham, GBR•  oes Aspirin Still Have a Role in Atrial Fibrillation? D Grond M. - Berlin, DEU•  hat Should the New Guideline Revisions on Stroke W Prevention Look Like? Kirchhof P. - Birmingham, GBR www.cardiostim.com 13
    • Advance programEuropean Heart Rhythm Association (EHRA) ProgramThursday June 14 / 14:00 - 15:30 Thursday June 14 / 16:00 - 17:30CRT IMPLANTATION AND FOLLOW-UP: THE CHALLENGES OF THE ASYMPTOMATICEHRA-HRS CONSENSUS STATEMENT PATIENT IN HEREDITARY SYNDROMESChair: Chair:Daubert J.C. - Rennes, FRA Priori S. G. - Pavia, ITASaxon L. - Los Angeles, USA Wolpert C. - Mannheim, DEU•  re-Implant Evaluation P •  symptomatic Patient with Long QT Syndrome A Brignole M. - Lavagna, ITA Schulze-Bahr E. - Munster, DEU• mplantation I •  symptomatic Patient with Brugada Syndrome A Singh J. - Boston, USA Brugada Terradellas P. - Brussels, BEL•  re-Discharge Evaluation P •  symptomatic Patient with Early Repolarization Syndrome A Leclercq C. - Rennes, FRA Haïssaguerre M. - Bordeaux, FRA•  evice and Heart Failure Follow-Up D Israel C.W. - Frankfurt, DEU •  symptomatic Patient with Catecholaminergic Polymorphic VT A•  esponse to CRT R Wanguemert Perez F. - Las Palmas, ESP Gold M. - Charleston, USA•  pecific Issues S Saxon L. - Los Angeles, USAThursday June 14 / 16:00 - 17:30 Thursday June 14 / 16:00 - 17:30CONTEMPORARY CONSIDERATIONS BASED ON TRANSLATIONAL APPROACHES IN ATRIALTECHNOLOGICAL DEVELOPMENTS IN CARDIAC FIBRILLATIONPACING Chair:Chair: Zaza A. - Milano, ITABotto G. - Como, ITA Goette A. - Magdeburg, DEUSutton R. - Monte Carlo, MCO •  enes and Mutations in Patients with Lone Atrial Fibrillation: G•  hould All Permanent Pacemakers Be MRI Compatible? S Do They Matter? Santini M. - Roma, ITA Olesen M. - Copenhagen, DNK• s Telemonitoring a New Necessity? I • onic Remodelling: From Bench to Bedside I Burri H. - Geneva, CHE Van Gelder I. C. - Groningen, NLD•  eadless Pacing: A Step Forward? L •  tructural Remodeling: Which Impact for Catheter Ablation? S Roberts P. - Southampton, GBR Schotten U. - Maastricht, NLD•  iological Pacemakers: A Futuristic Approach? B •  trial and Ventricular Oxidatives Stress during Atrial A Israel C. W. - Bielefeld, DEU Fibrillation Lendeckel U. - Greifswald, DEU14 www.cardiostim.com
    • Cardiostim 2012European Heart Rhythm Association (EHRA) ProgramFriday June 15 / 09:00 - 10:30 Friday June 15 / 11:00 - 12:30IMPROVING OUTCOMES IN THE CATHETER COMPLICATIONS RELATED TO ATRIALABLATION OF ATRIAL FIBRILLATION FIBRILLATION CATHETER ABLATIONChair: Chair:Kautzner J. - Praha, CZE Gaita F. - Asti, ITAKuck K. H. - Hamburg, DEU Hatala R. - Bratislava, SVK•  enervation of the Heart. The Role of gP Ablation in Atrial D •  revalence and Predictors of Complications of Radiofrequency P Fibrillation Treatment Catheter Ablation for Atrial Fibrillation Pokushalov E. - Novosibirsk, RUS Kautzner J. - Praha, CZE•  arly Ablation of Atrial Fibrillation. Would We Have Better E •  atheter Ablation on Uninterrupted Warfarin: Is It Safe? C Long-Term Results in the Future? Schilling R. - London, GBR Kirchhof P. - Birmingham, GBR • ncidence of Silent Cerebral Thromboembolic Lesions after I•  atheter Ablation of the Long-Standing Persistent Atrial C Atrial Fibrillation Ablation: Predictive Factors? Fibrillation. Where We Are Now? Scaglione M. - Asti, ITA Willems S. - Hamburg, DEU •  ong-Term Rates of Death, Stroke, and Dementia Following L•  urrent Standard of Care in Atrial Fibrillation Ablation C Atrial Fibrillation Ablation Jaïs P. - Bordeaux, FRA Day J. - Salt Lake City, USAFriday June 15 / 09:00 - 10:30 Friday June 15 / 11:00 - 12:30THE COMPLEX PACEMAKER IMPLANTATION CONTINUOUS MONITORING IN ATRIALChair: FIBRILLATION MANAGEMENT. NEW SCIENCEDavy J. M. - Montpellier, FRA OR NEW TRUTH?Ponikowski P. - Wroclaw, POL Chair: Lewalter T. - Bonn, DEU•  evice Implant in Case of Subclavian Vein Occlusion D Zupan I. - Ljubljana, SVN Bracke F. - Eindhoven, NLD• mplantation of a Pacing System in GUCH Patients I •  ymptomatic/Asymptomatic Events after AF Ablation S Morgan J. M. - Southampton, GBR Hindricks G. - Leipzig, DEU•  acing Considerations in Pediatric Patients P •  nticoagulation/Antiarrhythmic Management after AF Ablation A Cantu F. - Bergamo, ITA Kirchhof P. - Birmingham, GBR•  acemaker Therapy after TAVI Procedure P •  F Burden in Assessment of Long-Term Success after AF A Wissner E. - Hamburg, DEU Ablation Puererfellner H. - Linz, AUT •  anagement of Early Post-Operative Period. Who Will Need M Early Reablation? Pokushalov E. - Novosibirsk, RUS www.cardiostim.com 15
    • Advance programEuropean Heart Rhythm Association (EHRA) ProgramFriday June 15 / 14:00 - 15:30 Friday June 15 / 16:00 - 17:30ADVANCES IN ROBOTIC AND 3D MAPPING DIAGNOSTIC EVALUATION OF SYNCOPE INTECHNOLOGIES FOR ATRIAL FIBRILLATION SPECIAL PATIENT GROUPSABLATION Chair:Chair: Morgan J. M. - Southampton, GBRKautzner J. - Praha, CZE Theodorakis G. - Athens, GRCSantini M. - Roma, ITA •  atients with Bundle Branch Block P•  emote Magnetic Catheter Navigation: Is It the «Gold Standard»? R Moya A. - Barcelona, ESP Ernst S. - Hamburg, DEU •  yncope in Athletes S•  ethods, Efficacy, and Safety of Robotic Catheter Ablation for M Flevari P. - Halandri, GRC Atrial Fibrillation •  yncope in the Elderly: Particularities S Pisapia A. - Marseille, FRA Kenny R. A. - Dublin, IRL•  hree-Dimensional Rotational Angiography: A New Online T •  yncope Unit: A New Necessity? S Imaging Tool Brignole M. - Lavagna, ITA Noelker G. - Bad Oeynhausen, DEU•  atheter Ablation of Atrial Fibrillation Using a New Non- C Fluoroscopic Sensor-Guided 3D Navigation Tool Hindricks G. - Leipzig, DEUFriday June 15 / 14:00 - 15:30 Friday June 15 / 16:00 - 17:30MANAGEMENT OF PATIENTS WITH ARRHYTHMIAS IN WOMEN: STATE OF THEDEFIBRILLATOR SHOCKS: STATE-OF-THE ART EVIDENCEChair: Chair:Boriani G. - Bologna, ITA Borggrefe M. - Mannheim, DEUMorgan J. M. - Southampton, GBR Heidbüchel H. - Leuven, BEL• ncidence, Predictors and Impact on Mortality I •  anaging Arrhythmias in Pregnancy: What’s in the Guidelines? M van Rees H. - Den Haag, NLD Blomstrom-Lundqvist C. - Uppsula, SWE• CD Configuration and Programming to Optimise Shock I •  ender Differences in Atrial Fibrillation G Treatment Mont L. - Barcelona, ESP Katz A. - Ashkelon, ISR •  utcomes in Women Undergoing Electrophysiological O•  esults of Catheter Ablation in Patients with Shocks R Procedures Arenal Maiz A. - Madrid, ESP Santangeli P. - Austin, USA•  ow to Manage Patient Anxiety H • mplantable Cardioverter Defibrillators in Women I Ladwig K. H. - München, DEU Zupan I. - Ljubljana, SVN16 www.cardiostim.com
    • Cardiostim 2012European Heart Rhythm Association (EHRA) ProgramFriday June 15 / 16:00 - 17:30 Saturday June 16 / 09:00 - 10:30NEW ENERGIES AND TECHNOLOGIES TO TREAT CERTIFICATION: FIGHTING AGAINST INEQUALITYATRIAL FIBRILLATION IN HEALTH CARE ACROSS BORDERSChair: Chair:Davies W. - London, GBR Auricchio A. - Lugano, CHEKuck K. H. - Hamburg, DEU Nielsen J. C. - Aarhus, DNK•  apping and Pulmonary Vein Isolation Using the PVAC M •  Powerful Tool for Improvement in Health Care A Duytschaever M. - Brugges, BEL Zeppenfeld K. - Leiden, NLD•  ryoballoon Pulmonary Vein Isolation Guided by Real-Time PV C •  odels to Be Listened: UK M Potential Recording Linker N. J. - Middlesbrough, GBR Hoffmann E. - Munich, DEU •  ertification of Allied Professionals C•  ow-Level Vagosympathetic Nerve Stimulation: A New Target L Nolan P. - Galway, IRL for Atrial Fibrillation Suppression? •  ertification in Europe: Differences with and Lessons from USA C Jackman W. M. - Oklahoma City, USA Arribas Ynsaurriaga F. - Madrid, ESP•  inimally Invasive Surgical Techniques: For Which Patients? M La Meir M. - Maastricht, NLD Saturday June 16 / 09:00 - 10:30 DEBATES AND CONTROVERSIES IN THE ANTITHROMBOTIC MANAGEMENT OF ATRIAL FIBRILLATION Chair: Savelieva I. - London, GBR •  ow Risk Patients with Atrial Fibrillation Can Be Treated with L No Antithrombotic Therapy: FOR Fauchier L. - Tours, FRA •  ow Risk Patients with Atrial Fibrillation Can Be Treated with L No Antithrombotic Therapy: AGAINST Rasmussen L. H. - Aalborg, DNK •  ntiplatelet Therapy Should Be Added to Anticoagulant Therapy A in Patients with Atrial Fibrillation and Vascular Disease: FOR Rubboli A. - Bologna, ITA •  ntiplatelet Therapy Should Be Added to Anticoagulant Therapy A in Patients with Atrial Fibrillation and Vascular Disease: AGAINST Marin F. - Murcia, ESP www.cardiostim.com 17
    • Advance programEuropean Heart Rhythm Association (EHRA) ProgramSaturday June 16 / 11:00 - 12:30 Saturday June 16 / 11:00 - 12:30ANTIARRHYTHMIC DRUGS FOR ATRIAL NURSE-LED INTERVENTIONS FOR PATIENTSFIBRILLATION WITH ARRHYTHMIASChair: Chair:Capucci A. - Ancona, ITA Linker N. J. - Middlesbrough, GBRvan Gelder I. C. - Groningen, NLD Zeppenfeld K. - Leiden, NLD•  asics of Ion Channel Antiarrhythmic Drugs for Prevention of B •  OPE-ICD Trial: Comprehensive Rehabilitation for Patients C Atrial Fibrillation with Implantable Defibrillators Dobrev D. - Heidelberg, DEU Kikkenborg Berg S. - Copenhagen, DNK•  asics of Upstream Therapies for Prevention of Atrial Fibrillation B •  educing Psychological Distress for Patients with Implantable R Goette A. - Magdeburg, DEU Defibrillators• on Channel Antiarrhythmic Drugs for Prevention of Atrial Fibrillation I Dunbar S. - Atlanta, USA Crijns H. J. - Maastricht, NLD • mplementing a Nurse-Led Atrial Fibrillation Clinic I•  pstream Therapies for Prevention of Atrial Fibrillation U Hendriks J. M. L. - Maastricht, NLD Savelieva I. - London, GBR •  alpitations: Effectiveness of A Nurse-Led Clinic P Smallwood A. - Wolverhampton, GBRIn parallel with the scientific sessions, EHRA will hold a General Assembly to update members and attendees on its activities, whilemeetings of various committees and working groups will take place throughout the Congress. EHRA Membership 2012, DISCOVER YOUR BENEFITS ON OUR WEB SITE •  pecial registration fee for EHRA educational courses S •  ree registration for the EHRA Webinars (e-learning) F •  5% discount on EHRA Certification Examinations 1 • 10% off all cardiology publications from Oxford University Press (OUP). • Reduced fee for the EP Europace journal •  xclusive access to EHRA Training Fellowships and a selection of EHRA Educational Content Online E •  utomatic ESC membership and benefits: Free ESC Pocket Guidelines at the ESC Congress, A Discount prices on the ESC Educational Products, Special subscription prices on ESC Journals (including EHJ), Receive ESC congresses related information, Receive ESC Educational Programme information, A personal European Membership Card (currently for members of some National Cardiac Societies only) • Receiving the EHRA E-newsletter • Voting rights More at WWW.ESCARDIO.ORG/EHRA18 www.cardiostim.com
    • Cardiostim 2012Basic ElectrophysiologyChairman: D. Zipes - Indianapolis, USA Scientific Committee Ackerman M. - Rochester, USA Nattel S. - Montreal, CAN Anderson M.E. - Iowa City, USA Priori S. G. - Pavia, ITA Antzelevitch C. - Utica, USA Roden D.M. - Nashville, USA Borggrefe M. - Mannheim, DEU Rosen M. R. - New York, USA Boyden P. - New York, USA Rosenbaum D.S. - Cleveland, USA Chen P.S. - Indianapolis, USA Rudy Y. - St Louis, USA Delmar M. - New York, USA Saffitz J. - Boston, USA Ideker R. - Birmingham, USA Schwartz P. J. - Pavia, ITA Jalife J. - Ann Arbor, USA Tomaselli G. - Baltimore, USA Kleber A. - Bern, CHE Trayanova N. A. - Baltimore, USA London B. - Pittsburgh, USA Weiss J. - Los Angeles, USA Mazgalev T.N. - Cleveland, USA Wilde A. M. - Amsterdam Zuidoost, NLD Moss A.J. - Rochester, USA TRANSLATIONAL DISCOVERIES IN CARDIAC ELECTROPHYSIOLOGY: From Cell to BedsideWednesday June 13 / 09:00 - 10:30 Wednesday June 13 / 11:00 - 12:30CARDIAC STEM CELLS AND GENE THERAPY NEW IMAGING TECHNIQUESChair: Chair:Cohen I. - Stony Brook, USA Kalman J. - Melbourne, AUSFast V. - Birmingham, USA Mazgalev T.N. - Cleveland, USA•  aking Hearts Regenerate M •  lectrocardiographic Imaging to Understand Arrhythmia E Pedrazzini T. - Lausanne, CHE Mechanisms•  ardiac Differentiation of Human Keratinocytes Derived from C Rudy Y. - St. Louis, USA Plucked Hair Follicles •  imulations to Predict Sites of VT Ablation S Binah O. - Haifa, ISR Trayanova N. A. - Baltimore, USA •  RI for Risk Prediction of Arrhythmogenic Areas M• nduced Pluripotent Stem Cells from Patients with Inherited I Halperin H. - Baltimore, USA Arrhythmias •  hat Are the Clinical Implications? W January C. T. - Madison, USA Borggrefe M. - Mannheim, DEU•  hat Are the Clinical Implications? W •  eneral Discussion G Rosen M. R. - New York, USA• General Discussion www.cardiostim.com 19
    • Advance programBasic ElectrophysiologyWednesday June 13 / 14:00 - 15:30 Thursday June 14 / 09:00 - 10:30MYOCYTE-FIBROBLAST INTERACTIONS IN CONTRIBUTION OF GENETICS TONORMAL AND DISEASED MYOCARDIUM UNDERSTANDING MECHANISMS AND RISKChair: Chair:Kleber A. - Bern, CHE Sanders P. - Adelaide, AUSVos M. - Utrecht, NLD Lazzara R. - Oklahoma City, USA•  yocyte Fibroblast Interaction M •  xperimental Models to Explain Inherited Diseases E Kohl P. - London, GBR Antzelevitch C. - Utica, USA•  yofibroblasts as Arrhythmia Triggers M •  athology to Explain Phenotype P Rohr S. - Bern, CHE Basso C. - Padova, ITA•  lectromechanical Consequences of Adult Cardiomyocyte E •  ellular Electrophysiology to Explain Clinical Phenotypes C Myofibroblast Interactions Napolitano C. - Pavia, ITA Jalife J. - Ann Arbor, USA •  hat Are the Clinical Implications? W•  hat Are the Clinical Implications? W Moss A. J. - Rochester, USA Duffy H. - Boston, USA • General Discussion• General DiscussionWednesday June 13 / 16:00 - 17:30 Thursday June 14 / 11:00 - 12:30CARDIAC ION CHANNELS AND DOES GENETIC TESTING FOR SUDDEN DEATHMACROMOLECULAR COMPLEXES IN HEALTH HELP IN CLINICAL PRACTICE?AND DISEASE Chair:Chair: Tseng G. N. - Richmond, USAFishman G. - New York, USA Priori S. G. - Pavia, ITAFedorov V. - Columbus, USA • Syndrome•  acromolecular Complexes and the Control of Cardiac Ion M Schwartz P. J. - Pavia, ITA Channel Expression and Distribution •  rugada Syndrome and CPVT B Abriel H. - Bern, CHE Brugada P. - Aalst, BEL• ntercalated Disc as a Macromolecular Complex Niche and Its I • Hypertrophic Cardiomyopathy Role in ARVC Maron B. - Minneapolis, USA Delmar M. - New York, USA •  ut of Hospital Cardiac Arrest O•  AGUK Proteins Are Important in Ion Channel Diseases M Chugh S. S. - Los Angeles, USA Hatem S. - Paris, FRA •  hat Are the Clinical Implications? W•  hat Are the Clinical Implications? W Viskin S. - Tel Aviv, ISR Coronel R. - Amsterdam, NLD• General Discussion20 www.cardiostim.com
    • Cardiostim 2012Basic ElectrophysiologyThursday June 14 / 14:00 - 15:30 Friday June 15 / 09:00 - 10:30THE INTERCALATED DISC AND ROLE OF CaMKII IN ARRHYTHMIASARRHYTHMOGENIC CARDIOMYOPATHY Chair:Chair: Maier L. - Goettingen, DEUPoelzing S. - Salt Lake City, USA Gilmour R. - Ithaca, USAEhrlich J. - Frankfurt, DEU •  aMKII Regulation of Ion Channels C•  ased on Science, What Is the Best Name for Arrhythmogenic B Pitt G. - Durham, USA Right Ventricular Cardiomyopathy? •  aMKII Regulation of RyR Receptors and Ca Cycling C McKenna W. - London, GBR Wehrens X. H. - Houston, USA•  ell-Cell Communication in ARVC C •  ole of CaMKII in Cardiac Arrhythmias R Greene K. - Chicago, USA Mohler P. J. - Columbus, USA•  rrhythmia Mechanisms and Therapy A •  aMKII as a Potential Antiarrhythmic Target C Calkins H. - Baltimore, USA Maier L. - Goettingen, DEU•  hat Is Needed for a Cure? W •  hat Are the Clinical Implications? W Thiene G. - Padova, ITA Rosenbaum D. S. - Cleveland, USA•  hat Are the Clinical Implications? W Marcus F. - Tucson, USAThursday June 14 / 16:00 - 17:30 Friday June 15 / 11:00 - 12:30UNDERSTANDING ATRIAL FIBRILLATION ROLE OF THE AUTONOMIC NERVOUS SYSTEMChair: IN ARRHYTHMOGENESISHocini M. - Bordeaux, FRA Chair:Probst V. - Nantes, FRA Yamada K. - St. Louis, USA Franz M. - Washington, USA•  otassium Channel Remodeling P Nattel S. - Montreal, CAN •  ympathetic-Vagal Interactions in Conscious Dogs S•  emodeling of Calcium Handling R Lin S- F. - Indianapolis, USA Dobrev D. - Heidelberg, DEU •  agal Modulation of Atrial Arrhythmias V• Structural Remodeling Po S. - Oklahoma City, USA Allessie M. - Maastricht, NLD •  agal Modulation of Inflammation V•  hat Are the Clinical Implications? W Sabbah H. - Detroit, USA Natale A. - Austin, USA •  hat Are the Clinical Implications? W• General Discussion Goldberger J. - Chicago, USA • General discussion www.cardiostim.com 21
    • Advance programBasic ElectrophysiologyFriday June 15 / 14:00 - 15:30 Philippe Coumel SessionSMALL CONDUCTANCE CALCIUM-ACTIVATED Introduction: from Mechanism to Process.POTASSIUM CHANNELS (SK) AND CARDIAC Paradigm Shift?ARRHYTHMIAS Wednesday June 13 / 09:00 - 10:30Chair: ATRIAL FIBRILLATION: DEALING WITHLakatta E. - Baltimore, USAOpthof T. - Utrecht, NLD COMPLEXITY Chair:•  hat Are SK Channels? W Guiraudon G.M.- London, CAN Chiamvimonvat N. - Chicago, USA Klein G. J. - London, CAN•  K Channels and Ventricular Arrhythmias in Heart Failure S • ntrinsic Autonomic Cardiac Nervous System: New Physiology I Chen P- S. - Indianapolis, USA or Deregulation? Has Neuroablation Predictable Long-Term•  K Channels Modulate Cardiogenesis S Effects? Liebau S. - Ulm, DEU Cardinal R. - Montreal, CAN•  K Channels and Genetic Basis of Atrial Fibrillation S •  nderstanding the Complexity of the Substrate of Human AF U Ellinor P. - Boston, USA Allessie M. - Maastricht, NLD•  hat Are the Clinical Implications? W •  hen Complexity Beats Ablation? Alternative Interventions to W Myerburg R. J. - Miami, USA Restore Chronotropic Function, and Stroke Prevention Guiraudon G.M. - London, CANFriday June 15 / 16:00 - 17:30ROLE OF miRNAs IN ARRHYTHMIASYNDROMESChair:Grunnet M. - Copenhagen, DNKBoyden P. - New York, USA•  hy All the Interest in miRNAs? W Pinto Y. - Amsterdam, NLD• Hypertrophic Cardiomyopathy Ackerman M. - Rochester, USA•  ong QT Syndrome L Wilde A. M. - Amsterdam Zuidoost, NLD• Dilated Cardiomyopathy Engelhardt S. - Munich, DEU•  hat Are the Clinical Implications? W Roden D. M. - Nashville, USA22 www.cardiostim.com
    • Cardiostim 2012Complex Electrophysiology and Ablation TechniquesCourse Directors:Scheinman M. - San Fransciso, USAO’Neill M. - London, GBRProbst V. - Nantes, FRASacher F. - Bordeaux, FRAWednesday June 13 / 11:00 - 12:30 Wednesday June 13 / 16:00 - 17:30ATRIAL FIBRILLATION ABLATION I ATRIAL FIBRILLATION ABLATION III•  echanisms of Atrial Fibrillation. Implication for Ablation M •  ryo Balloon Ablation of AF C Strategies Ellenbogen K. - Richmond, USA Nattel S. - Montreal, CAN •  atients Selection for AF Ablation P•  eal Time Mapping to Guide Atrial Fibrillation Ablation R O’Neill M. - London, GBR Narayan S. - San Diego, USA •  ow to Identify Targets and End-Points for Atrial Fibrillation H•  MR Imaging:” Does It Have a Role in Atrial Fibrillation “ Ablation? Ablation? Asirvatham S. J. - Rochester, USA Marrouche N. F. - Salt Lake City, USA •  ong-Term Outcome for Atrial Fibrillation Ablation L•  trial Fibrillation Ablation for Patients with Long Standing A Knecht S. - Brussels, BEL Persistent Atrial Fibrillation Sanders P. - Adelaide, AUSWednesday June 13 / 14:00 - 15:30ATRIAL FIBRILLATION ABLATION II•  ewer Left Atrial Appendage Occlusion and Ligation Devices N for Stroke Prevention: Should They Be Part of an Atrial Fibrillation Procedure? Lee R. J. - San Francisco, USA•  picardial Ablation of Atrial Fibrillation E Michaud G. F. - Boston, USA•  atheter Ablation of Atrial Fibrillation Using a Non- C Fluoroscopic Sensor Navigation Device Hindricks G. - Leipzig, DEU•  ontact Monitoring and New Ablation Toys C Wright M. - London, USA www.cardiostim.com 23
    • Advance programComplex Electrophysiology and Ablation TechniquesThursday June 14 / 09:00 - 10:30 Thursday June 14 / 14:00 - 15:30ATRIAL FLUTTER ABLATION PAROXYSMAL SUPRAVENTRICULAR•  nusual forms (Double Loop, Lower Loop and Intra-Isthmus U TACHYCARDIA ABLATION II Reentry) •  blation of the Patient with Atrio-Fascicular Pathways A Mounsey J. P. - Chapel Hill, USA Jackman W. M. - Oklahoma City, USA•  pproach to the Ablation of Post Atrial Fibrillation Induced Left A •  blation of Atrial Tachycardia/Accessory Pathways from the A Atrial Flutter Aortic Sinus Knecht S. - Brussels, BEL Kuck K. H. - Hamburg, DEU•  iagnoses and Ablation of Right Sided Flutter D •  ow to Best Diagnose SVT Mechanisms? H Yagi T. - Sendai, JPN Callans D. - Philadelphia, USA •  resentation of Complex Cases (SVT) P Scheinman M. - San Fransciso, USAThursday June 14 / 11:00 - 12:30 Thursday June 14 / 16:00 - 17:30PAROXYSMAL SUPRAVENTRICULAR Interactive sessionTACHYCARDIA ABLATION I • nteractive session I•  echanisms and Results of Ablative Therapy for Patients with M Badhwar N. - San Francisco, USA Focal Junctional Tachycardia Kalman J. M. - Parkville, AUS Cheng J. - Houston, USA Kuck K. H. - Hamburg, DEU Callans D. - Philadelphia, USA•  blation of Complex ANVRT Circuits A Badhwar N. - San Francisco, USA•  iagnoses, Therapy and Results of Ablative Therapy for D Patients with Manifest or Concealed Nodo-Fascicular (Ventricular) Pathways Badhwar N. - San Francisco, USA•  ocalization and Ablation of Atrial Tachycardias L Kalman J. M. - Parkville, AUS24 www.cardiostim.com
    • Cardiostim 2012Complex Electrophysiology and Ablation TechniquesFriday June 15 / 09:00 - 10:30 Friday June 15 / 14:00 - 15:30VENTRICULAR TACHYCARDIA ABLATION I VENTRICULAR TACHYCARDIA ABLATION III -•  ole of Identifying and Ablating Late Potentials R Debates Jaïs P. - Bordeaux, FRA •  atients with 1st Appropriate ICD Shock Should be Treated P•  ecognition and Ablation of Intraseptal VT R with Ablation Bogun F. - Ann Arbor, USA PRO: Sapp J. - Halifax, CAN•  oes Cardiac MRI Identify the Critical VT Isthmus? D CON: TBD Dickfeld T. - Baltimore, USA •  blation of AF: First Line Therapy in Electrical Storms A•  he Role of Endocardial Unipolar Recordings for VT Ablation T PRO: Boyle N. - Los Angeles, USA Callans D. - Philadelphia, USA CON: Coromilas J. - New York, USAFriday June 15 / 11:00 - 12:30 Friday June 15 / 16:00 - 17:30VENTRICULAR TACHYCARDIA ABLATION II VENTRICULAR TACHYCARDIA ABLATION IV•  atheter Ablation of Fascicular Tachycardia in Practice C •  atheter Ablation of Patients with Arrhythmogenic Right C Nogami A. - Kanagawa, JPN Ventricular Dysplasia (ARVD)•  atheter Ablation of VT from Papillary Muscles C Reddy V. Y. - Boston, USA Kay N. - Birmingham, USA •  atheter Ablation of Patients with VT and Systemic Disease C•  F Ablation in Post MI Patients V (Sarcoid/Amyloid/Iron Overload/Myotonic Dystrophy) Snumowski L. - Warsaw, POL Arruda M. - Case Western, USA•  ong-Term Outcome after VF Ablation L •  blation of the Patient with Ischemic VT A Hocini M. - Bordeaux, FRA Soejima K. - Kawasaki, JPN •  ipolar Voltage Map vs. MR for Detection of Myocardial Scar B Gerstenfeld E. P. - Philadelphia, USA www.cardiostim.com 25
    • Advance programComplex Electrophysiology and Ablation TechniquesCases Discussion in ElectrophysiologyOrganized byKlein G.J. - London, CANSacher F. - Bordeaux-Pessac, FRAO’Neill M. - London, GBRSpeakers are invited to present 1 or 2 cases they found instructive or challenging. The problem might be diagnostic or related toablation complexity.Speakers should be prepared to be interrupted and participate in dialogue during the presentation and consider this in the lengthof their presentation.Saturday June 16 / 9:00 - 10:30 Saturday June 16 / 11:00 - 12:30THE CHALLENGING CASE - Part I THE CHALLENGING CASE - Part IIChair: Chair:Klein G. J. - London, CAN Klein G. J. - London, CANCallans D. - Philadelphia, USA Callans D. - Philadelphia, USAO’Neill M. - London, GBR O’Neill M. - London, GBRSkanes A. - London, CAN Skanes A. - London, CANState-of-the-Art in the Brugada SyndromeOrganized bySacher F. - Bordeaux-Pessac, FRAFriday June 15 / 09:00 - 10:30 Friday June 15 / 11:00 - 12:30THERAPEUTIC OPTIONS IN BRUGADA UNSOLVED ISSUES IN BRUGADA SYNDROMESYNDROME Chair: Wilde A. M. - Amsterdam Zuidoost, NLD•  isk Stratification in Brugada Syndrome R Antzelevitch C. - Utica, USA Delise P. - Trevise, ITA•  utcome after ICD Implantation O •  CN5A: Which Role in Brugada Syndrome? S Sacher F. - Bordeaux-Pessac, FRA Probst V. - Nantes, FRA•  F Ablation in Brugada Syndrome V •  rugada Syndrome Mechanism: Depolarization/Repolarization B Nademanee K. - Los Angeles, USA or Different Entities with a Same ECG Pattern Postema P.G. - Amsterdam, NLD •  alue of Electrophysiological Study for Risk Stratification: The V PRELUDE Study Priori S. G. - Pavia, ITA26 www.cardiostim.com
    • Cardiostim 2012Complex Electrophysiology and Ablation TechniquesNovel Approaches to Apply Mechanistic Insights to Complex Human ArrhythmiasOrganized byE. Pruvot - Lausanne, CHE & S. Narayan - San Diego, USAGoals: To discuss the implementation and practical application of principles and insights from basic science to understand and treathuman arrhythmias. Because the detailed mapping and tissue analyses for in silico, in vitro and in vivo animal models often cannotbe applied in patients, this session will also discuss technical innovations that have enabled successful translational patient studies.Thursday June 14 / 14:00 - 15:30 Thursday June 14 / 16:00 - 17:30MECHANISTIC APPROACHES TO COMPLEX MECHANISTICALLY-GUIDED THERAPIES FORARRHYTHMIAS - PART I: REPOLARIZATION HUMAN CARDIAC FIBRILLATION - PART II -ALTERNANS – TRANSLATING FUNDAMENTAL ATRIAL ARRHYTHMIASOBSERVATIONS TO CLINICAL PRACTICE FOR Chair:ATRIAL AND VENTRICULAR ARRHYTHMIAS Berenfeld O. - Ann Arbor, USAChair:Pruvot E. - Lausanne, CHE •  asic Science of Atrial Fibrillatory Sources: The Role of Rotors BNarayan S. - San Diego, USA vs Multiple Wavelets Jalife J. - Ann Arbor, USA•  rom Pulsus to Pulseless: The Saga of Cardiac Repolarization F •  ocalized Rotors and Focal Beats in Human Atrial Fibrillation L Alternans Narayan S. - San Diego, USA Rosenbaum D. S. - Cleveland, USA •  linical Application of Noninvasive Electrocardiographic C• ntermittent Atrial Tachycardia Promotes Repolarization I Imaging (ECGI) Alternans and Susceptibility to AF in a Free-Behaving Sheep Cuculich P. - St Louis, USA Model •  lectrogram Correlates of Localized Sources During AF E Pruvot E. - Lausanne, CHE Mansour M. - Boston, USA•  trial Repolarization Alternans as a Dynamic Substrate A •  ole of Imaging and Ablating Structural Obstacles to Treat R Promoting Wavebreaks in Human Paroxysmal and Persistent Human AF AF Marrouche N. F. - Salt Lake City, USA Narayan S. - San Diego, USA•  ERCA2A Overexpression as a Molecular Intervention to S Suppress Repolarization Alternans and Susceptibility of Cardiac Fibrillation Cutler M. - Cleveland, USA• ntracardiac Repolarization Alternans/Variability Predicts I Imminent Ventricular Tachyarrhythmias in ICD Recipients Swerdlow C. D. - Los Angeles, USA www.cardiostim.com 27
    • Advance programComplex Electrophysiology and Ablation TechniquesFriday June 15 / 09:00 - 10:30 Computer ModellingMECHANISTICALLY-GUIDED APPROACHES TO Organized by Maxime Sermasant - Sophia Antipolis, FRA from INRIAHUMAN CARDIAC FIBRILLATION - PART III - (Institut National de Recherche en Informatique et Automatique)VENTRICULAR ARRHYTHMIASChair:Shivkumar K. - San Diego, USA Thursday June 14 / 11:00 - 12:30•  rigger Mechanisms for Human Ventricular Fibrillation T COMPUTATIONAL ELECTROPHYSIOLOGY: Knecht S. - Bordeaux, FRA NOVEL TOOLS TO IMPROVE CLINICAL•  ecent Developments in Defibrillation and in Understanding R Ventricular Fibrillation UNDERSTANDING Ideker R. - Birmingham, USA Chair: Panfilov A. V. - Gent, BEL•  hat Is the Optimal Mapping Approach to Guide Ablation of W Rhode K. - London, GBR Human Ventricular Tachyarrhythmias? Shivkumar K. - Los Angeles, USA •  lectrotonic Modulation of Cardiac Repolarization in Health E•  ignal Processing Approaches to Guide Complex Ablation in S and Disease: Insights from a Combined Computational and the Atria and Ventricles Experimental Study Chen S.A. - Taipei, TWN Bernus O. - Bordeaux-Pessac, FRA•  ignal Processing Insights into the Mechanisms of Human S •  lectro-Mechanical Interaction – Is This Something the E Ventricular Arrhythmias Clinical Electrophysiologist Has to Care about or Is This only of Krummen D.E. - San Diego, USA Interest to the Cellular Researcher? Bijnens B. - Barcelona, ESP •  lectrical and Structural Characteristics of Border Zone in E Infarcted Swine: Insights from 3D MR Image-Based Computer Models, Histopathology and EP Data Pop M. - Toronto, CAN •  ardiac Radiofrequency Ablation Planning from Personalized C Biophysical Models Delingette H. - Sophia-Antipolis, FRA28 www.cardiostim.com
    • Cardiostim 2012Treatments of Atrial FibrillationAdvances and Controversies in Atrial Fibrillation (ACAF)Chairman:Naccarelli G. V. - Hershey, USABlanc J.J. - Brest, FRALévy S. - Marseille, FRAUnrestricted Educational Support: sanofi aventisThursday June 14 / 09:00 - 10:30 Thursday June 14 / 14:00 - 15:30ATRIAL FIBRILLATION I ATRIAL FIBRILLATION IIIChair: Chair:Naccarelli G. V. - Hershey, USA Santini M. - Rome, ITABoriani G. - Bologna, ITA Breithardt G. - Münster, DEU•  arly Attempts at Rhythm Control Slows Progression of AF E •  ovel Anticoagulants: Where Are We in 2012? N Crijns H. J. - Maastricht, NLD Naccarelli G. V. - Hershey, USA•  as Basic Science Helped Us Develop Better Pharmacologic H •  an Newer Anticoagulants Be Used Safely for Cardioversion C and Ablative Therapies for AF? of AF Patients? Allessie M. - Maastricht, NLD Aliot E. - Nancy, FRA•  pstream Therapy of AF – Is It All over but the Shouting? U •  ntiarrhythmic/Anticoagulant Drug Interactions: What Do We A Dorian P. - Toronto, CAN Know? Tamargo J. - Madrid, ESPThursday June 14 / 11:00 - 12:30 Thursday June 14 / 16:00 - 17:30ATRIAL FIBRILLATION II ATRIAL FIBRILLATION IVChair: Chair:van Gelder I. C. - Groningen, NLD Lévy S. - Marseille, FRACapucci A. - Ancona, ITA Vardas P. E. - Heraklion, GRC•  ronedarone in 2012: What is New? D •  symptomatic AF: Prognostic Implications A Le Heuzey J. Y. - Paris , FRA Blanc J. J. - Brest, FRA•  ALLAS: Why Was It Performed? Where Are We? P • s Catheter Ablation of AF Prothrombotic or Antithrombotic? I Hohnloser S. - Frankfurt, DEU Packer D. L. - Rochester, USA•  ronedarone and Ranolazine: Is a Combination Drug a Good D •  ole of Novel Anticoagulants During AF Ablation Procedures? R Idea ? Cappato R. - San Donato Milanese (MI), ITA Antzelevitch C. - Utica, USA www.cardiostim.com 29
    • Advance programNoninvasive ElectrocardiologyInternational Symposium on High Resolution ECG and Late Potentials, and NoninvasiveElectrophysiologyChairpersons:El-Sherif N. - USATuritto G. - USA SUDDEN CARDIAC DEATH - FROM MOLECULAR BIOLOGY TO CLINICAL MANAGEMENT: AN UNFINISHED ODYSSEYWednesday June 13 / 16:00 - 17:30 Thursday June 14 / 09:00 - 10:30CASE#1: 65 y/o male, h/o ASWMI; s/p CABGx3, CASE#2: 54 y/o female with no cardiac risk5 weeks ago; LVEF=38%, presents with a recent factors presents with CHF, LVEF=25%, and LBBBsyncopal episode Chair:Chair: Turitto G. - Brooklyn, USAEl-Sherif N. - Brooklyn, USA •  olecular Biology and Pathophysiology of Non-Ischemic M•  ost-MI Remodeling; Molecular and Electrophysiological P Cardiomyopathy Substrates Corrado D. - Padova, ITA El-Sherif N. - Brooklyn, USA •  RS Duration and Configuration. The Need to Modify Q•  re Noninvasive Risk Stratification of Post-MI Patients Still A Selection Criteria for CRT Relevant ? Zareba W. - Rochester, USA La Rovere M. T. - Pavia, ITA •  oes the Controversy of CRT-P vs CRT-D Still Exist? D•  ow to Risk Stratify SCD in Post-MI Patients with LVEF>35% H Klein H. - Rochester, USA Turitto G. - Brooklyn, USA •  anel consensus: How to Best Manage This Patient P•  anel consensus: How to Best Manage This Patient P30 www.cardiostim.com
    • Cardiostim 2012Noninvasive ElectrocardiologyThursday June 14 / 11:00 - 12:30 Thursday June 14 / 14:00 - 15:30CASE#3: 29 y/o male collapsed and CASE#4: 45 y/o male presents withspontaneously recovered during running one syncopal episode, normal 2-D echo.NY Marathon, ECG= LVH pattern, 2-D echo= ECG=prominent early repolarization wave insuggestive of hypertrophic cardiomyopathy inferior surface leadsChair: Chair:Lévy S. - Marseille, FRA Breithardt G. - Münster, DEU•  olecular Biology of Hypertrophic CMP M •  enign vs Malignant Early Repolarization B Ackerman M. - Rochester, USA Napolitano C. - Pavia, ITA•  athophysiology of SCD in Athletes P •  ontinuous Spectrum between Early Repolarization and C Thiene G. - Padova, ITA Brugada Syndrome•  isk Stratification of SCD in Athletes R Antzelevitch C. - Utica, USA Biffi M. - Bologna, ITA •  anel consensus: How to Best Manage This Case P•  anel consensus: How to Best Manage This Patient P •  pilogue: SCD in 2012 E Breithardt G. - Münster, DEU The platform to consult and free download ECG and Epidemiology data http://epdatabank.cardiostim.com www.cardiostim.com 31
    • Advance programNoninvasive ElectrocardiologyEducational Symposium of the International Society for Holter and Noninvasive Electrocardiology (ISHNE)Advances in Noninvasive ElectrocardiologyChairmen:Wojciech Zareba - Rochester, USASergio Dubner - Buenos Aires, ARGArthur J. Moss - Rochester, USAWednesday June 13 / 9:00 - 10:30 Wednesday June 13 / 16:00 - 17:30EARLY REPOLARIZATION: BENIGN VERSUS CHALLENGING ECG DIAGNOSISDANGEROUS? Moderators:Chair: Dubner S. - Buenos Aires, ARGStone P. H. - Boston, USA Steinberg J. - New York, USATuritto G. - New York, USA Piotrowicz R. - Warsaw, POL•  lectrophysiology of Early Repolarization E El-Sherif N. - New York, USA Thursday June 14 / 9:00 - 10:30•  Wave Syndrome and SCD J UPDATE ON METHODS IN THE RISK TBD STRATIFICATION OF SCD•  arly Repolarization in Athletes E Chair: Corrado D. - Padua, ITA Hombach V. - Ulm, DEU•  urrent State of the Early Repolarization Research C Oto A. - Ankara, TUR Stern S. - Tel-Aviv, ISR •  T Segment and NSVT – Revival of Classical Parameters? S Stone P. H. - Boston, USAWednesday June 13 / 14:00 - 15:30 •  olter-Based T Wave Alternans – How to Analyze It? HQUESTIONS IN OPTIMIZING BENEFITS OF CRT Verrier R. L. - Boston, USAChair: •  xercise-Induced T Wave Alternans – Is It Here to Stay? EMoss A. J. - Rochester, USA Klingenheben T. - Bonn, DEUHaigney M. - Bethesda, USA •  RV or QTV or Their Combination? H La Rovere M. T. - Pavia, ITA•  RT in RBBB Patients – Should We Abandon It? C Zareba W. - Rochester, USA•  ow Important Is the CRT Lead Location? H Klein H. - Munchen, DEU•  ptimizing AV and VV Interval in CRT Patients – Is It Needed? O Schuger C. - Detroit, USA•  RT in Atrial Fibrillation Patients – Who and How? C Steinberg J. - New York, USA32 www.cardiostim.com
    • Cardiostim 2012Noninvasive ElectrocardiologyThursday June 14 / 14:00 - 15:30 Friday June 15 / 14:00 - 15:30RISK STRATIFICATION OF SUDDEN AND TOTAL UPDATE ON INHERITED ARRHYTHMIAMORTALITY IN SPECIFIC GROUPS DISORDERS: DON’T MISS THE DIAGNOSIS -Chair: CASE-BASED PRESENTATIONDubner S. - Buenos Aires, ARG Chair:Goldberger J. - Chicago, USA Locati E. - Milano, ITA Zareba W. - Rochester, USA•  isk Stratification in Post-MI PCI-Treated Patients R Exner D. - Calgary, CAN •  ong QT Syndrome L•  isk Stratification in Diastolic Heart Failure R Moss A. J. - Rochester, USA TBD • ARVC•  isk Stratification in Diabetes R Marcus F. - Tucson, USA Hombach V. - Ulm, DEU • Brugada Syndrome•  isk Stratification in Atrial Fibrillation Patients R Breithardt G. - Münster, DEU Lombardi F. - Milan ITA • Anderson-Tawil Syndrome Tristani-Firouzi M. - Salt Lake City, USAThursday June 14 / 16:00 - 17:30 Friday June 15 / 16:00 - 17:30CHALLENGING ECG DIAGNOSIS: VT OR SVT CHALLENGING EGMS: APPROPRIATE ORModerators:Breithardt G. - Münster, DEU INAPPROPRIATE ICD THERAPY - INTERACTIVESchuger C. - Detroit, USA SESSION Moderators: Turitto G. - New York, USAFriday June 15 / 9:00 - 10:30 Rabinovitz R. - Buenos Aires, ARGQT VARIABILITY AND DYNAMICS Ritter P. - Bordeaux, FRAChair:Verrier R. L. - Boston, USALa Rovere M. T. - Pavia, ITA• QT Variability Haigney M. - Bethesda, USA•  T Beat-to-Beat in Drug Studies Q Couderc JP. - Rochester, USA•  xercise-Induced QT Changes E TBD• QT/RR Slope Locati E. - Milano, ITA www.cardiostim.com 33
    • Advance programMain Trials in the Management of Atrial Fibrillation Chairmen:Waldo A.L. - Cleveland, USACamm A.J. - London, GBRPratt C. - Houston, USAWednesday June 13 / 09:00 - 10:30 Wednesday June 13 / 14:00 - 15:30THE NEW ORAL ANTICOAGULANTS (OACs) FOR CLINICAL TRIALS IN AF - INFLUENCE ONSTROKE PREVENTION IN AF - Part 1 GUIDELINES - DISCUSSION AND PERSPECTIVEChair: Chair:Waldo A. L. - Cleveland, USA Pratt C. M. - Houston, USA•  OCKET AF - Rivaroxaban for the Treatment of Atrial R •  entricular Rate Control [Really RATE II in perspective] V Fibrillation van Gelder I. C. - Groningen, NLD Breithardt G. - Münster, DEU •  hythm Control [includes prior Rate vs Rhythm trials and R•  ivaroxaban in DVT and ACS Trials - An OAC for All Seasons? R dronedarone story] Verheught F. W. A. - NLD Saksena S. - New Brunswick, USA• Dabigatran AF Sub-Studies •  evices (BiV pacemakers, ICDs, etc.) D Hohnloser S. - Frankfurt, DEU Daubert J. C. - Rennes, FRAWednesday June 13 / 11:00 - 12:30 Wednesday June 13 / 16:00 - 17:30THE NEW ORAL ANTICOAGULANTS (OACS) FOR AF ABLATION TRIALSSTROKE PREVENTION IN AF - Part 2 Chair:Chair: Page R. L. - Seattle, USACamm A. J. - London, GBR •  ate Follow-Up – Efficacy and Safety L• ARISTOTLE (Apixaban) Kuck K. H. - Hamburg, DEU Wallentin L. - Uppsala, SWE • Ongoing Trials•  VERROES – Implications for Apixaban in Other Trials A Ruskin J. N. - Boston, USA Waldo A. - Cleveland, USA •  blation in Heart Failure A•  NGAGE AF – (Edoxaban) E Jaïs P. - Bordeaux, FRA Weitz J. - Toronto, CAN34 www.cardiostim.com
    • Cardiostim 2012Acute Cardiac Care: Management of SCDSession organized in cooperation with the Working Group on Acute Cardiac Care of the EuropeanSociety of Cardiology (ESC)Chairmen:Vrints C. - Edegem, BELGorenek B. - Eskisehir, TURWednesday June 13 / 11:00 - 12:30 Thursday June 14 / 09:00 - 10:30ARRHYTHMIAS IN PRIMARY PCI ARRHYTHMIAS IN ACUTE CARDIAC CAREChair: SETTINGClemmensen P. M. - Copenhagen, DNK Chair:Quinn T. - GBR Vrints C. - Edegem, BEL N. Danchin - Paris, FRA• ncidence and Prognostic Impact I Lettino M. - Roma, ITA •  cute Arrhythmias in Adult Congenital Heart Disease A•  ow to Prevent and Manage Reperfusion Arrhythmias H Price S. - GBR Gorenek B. - Eskisehir, TUR •  trial Fibrillation in Patients with Acute MI; Prognostic Impact A•  ew Onset Atrial Fibrillation N and Treatment Options Manolis A. S. - Athens, GRC Zeymer U. - DEU•  oronary Intervention during VF /VT or Asystole C •  trial Fibrillation in Acute Heart Failure A Clemmensen P. M. - Copenhagen, DNK Vrints C. - Edegem, BEL •  lectrical Storm in Patients with ICD E Santini M. - Roma, ITA The platform to consult and free download ECG and Epidemiology data http://epdatabank.cardiostim.com www.cardiostim.com 35
    • Advance programPacing, ICDs and CRTCourse DirectorsHayes D. - Rochester, USARitter P. - Bordeaux, FRA & Bordeaux TeamCannom D. S. - Los Angeles, USASingh J. - Boston, USAAbi-Samra F. - New Orleans, USACRTWednesday June 13 / 09:00 - 10:30 Wednesday June 13 / 11:00 - 12:30SELECTION OF CRT PATIENTS: GUIDELINES CAN RESPONSE TO CRT BE BETTERAND BEYOND PREDICTED BY…Chair: Chair:Mabo P. - Rennes, FRA Butter C. - Bernau, DEUKottkamp H. - Zurich, CHE Defaye P. - Grenoble, FRA•  RT Guidelines: Interpretation and Differences of ESC & C •  car Zone Location and Transmurality? S American Guidelines Mela T. - Boston, USA TBD •  imited Regional Delayed Contraction in Recommended L•  atient with QRS between 120 and 150 ms: Are They P Candidates? Candidates for CRT? Spragg D. - USA Holmeister J. - Zurich, CHE •  ssessment of Segmental Contractile Reserve? A•  hould CRT Be Implemented during or after Cardiac Surgery S Gasparini M. - Rozzano (MI), ITA in Patients with Low LVEF? •  resence of Co-Morbidities (RV Dysfunction, Renal Failure, P Leclercq C. - Rennes, FRA Ageing, Diabetes etc..)?•  hould CRT Be Routinely Used in patients with Spontaneous S Van Bommel R. - Leiden, NLD Complete Heart Block and after AVN Ablation? Gutleben K. J. - Bad Oeynhausen, DEU•  hould Patients with RBBB Be Implanted with a CRT Device? S Botto G. - Como, ITA36 www.cardiostim.com
    • Cardiostim 2012Pacing, ICDs and CRTWednesday June 13 / 14:00 - 15:30 Thursday June 14 / 11:00 - 12:30DURING IMPLANTATION, CAN CRT BE ROLE OF DIFFERENT PROVIDERS TO ASSUREOPTIMIZED DURING IMPLANT BY… CRT SUCCESSChair: Chair:Ellenbogen K. - Richmond, USA Vogt J. - Bad Oeynhausen, DEU Lau C. P. - Hong Kong, CHN•  ocalization of Time-Delayed Activated Areas and Scar L Zones? •  hat Can Surgeons Add to the Care/Success of CRT W Rinaldi A. - London, GBR Patients?•  hange in QRS Width and/or Morphology? C Jansens J. L. - Brussels, BEL Daubert J. C. - Rennes, FRA •  hat Can EP Specialists Do for CRT Patients? W• Real-Time Echo Assessment? Hayes D. - Rochester, USA Van Bommel R. - Leiden, NLD •  hat Can Heart Failure Experts Do for CRT Patients? W•  easurement of Hemodynamic Parameters? M Parks K. A. - Boston, USA Whinnett Z. - London, GBR •  hat Can Specialists In Imaging Techniques Do for CRT W Patients? Cochet H. - Bordeaux, FRAWednesday June 13 / 16:00 - 17:30TECHNIQUES FOR LV LEAD PLACEMENTChair:Gras D. - Nantes, FRABelott P. H. - El Cajon, USA• Balloon Anchoring Cha Y. M. - Rochester, USA• Coronary Venoplasty TBD• Snares Worley S. - Lancaster, USA• Transeptal Derval N. - Bordeaux, FRA www.cardiostim.com 37
    • Advance programPacing, ICDs and CRTThursday June 14 / 14:00 - 15:30 Friday June 15 / 09:00 - 10:30YOUR OPINION - CRT ISSUES - PART I YOUR OPINION - CRT ISSUES - Part IIIChair: Chair:Linde C. M. - Stockholm, SWE Biffi M. - Bologna, ITAOto A. - Ankara, TUR Prinzen F. W. - Maastricht, NLD•  ro - There Is a Role for CRT in Patients with Narrow P •  ro - Endocardial LV Pacing Is Better than Epicardial LV P (< 120 ms) QRS Pacing Ruschitzka F. - Zurich, CHE Singh J. - Boston, USA•  ontra - There Is a Role for CRT in Patients with Narrow C •  ontra - Endocardial LV Pacing Is Better than Epicardial LV C (< 120 ms) QRS Pacing Beshai J. F. - Chicago, USA Derval N. - Bordeaux, FRA•  RT in Heart Failure Patients with Preexistent or New C •  ro - CCM Is an Efficient Therapy for Heart Failure P Persistent Atrial Fibrillation - I Ablate the His Bundle Ricci R. - Rome, ITA Leclercq C. - Rennes, FRA •  ontra - CCM Is an Efficient Therapy for Heart Failure C•  RT in Heart Failure Patients with Preexistent or New C Butter C. - Bernau, DEU Persistent Atrial Fibrillation - I Ablate the Atria Singh J. - Boston, USAThursday June 14 / 16:00 - 17:30 Friday June 15 / 11:00 - 12:30YOUR OPINION - CRT ISSUES - PART II CRT ISSUES - PART IV: OPINIONS REGARDINGChair: TECHNIQUES FOR LV LEAD PLACEMENTAbi-Samra F. M. - New Orleans, USA Chair:Lewalter T. - Bonn, DEU Israel C. W. - Bielefeld, DEU Abi-Samra F. M. - New Orleans, USA•  ro - Some Patients with LBBB Can Be Cured Thanks to the CRT P Blanc J. J. - Brest, FRA •  Choose That Sheath in That Case I•  ontra - Some Patients with LBBB Can Be Cured Thanks to C Morgan J. M. - Southampton, GBR the CRT •  Choose That Lead in That Patient I Jourdain P. - Pontoise, FRA Gras D. - Nantes, FRA•  ro - Now, I Apply CRT only in Heart Failure Patients with QRS P •  Decide to Stop or Continue the Procedure in That Case I ≥ 150ms (Reference to Complications and Duration of Procedure) Kautzner J. - Praha, CZE Worley S. - Lancaster, USA•  ontra - Now, I Apply CRT only in Heart Failure Patients with C QRS ≥ 150ms Linde C. M. - Stockholm, SWE38 www.cardiostim.com
    • Cardiostim 2012Pacing, ICDs and CRTFriday June 15 / 14:00 - 15:30 Friday June 15 / 16:00 - 17:30FOLLOW-UP OF CRT PATIENTS HOW TO IDENTIFY RESPONDERS /Chair: NON-RESPONDERS TO CRT?Ricci R. - Roma, ITA Chair: Blanc J. J. - Brest, FRA•  anagement of Non-Responders M Ovsyshcher E. - Beersheva, ISR Parks K. A. - Boston, USA•  anagement of Super Responders M •  hould a Universal Definition of a CRT-Responder Be Agreed S Stellbrink C. - Bielefeld, DEU Upon?• Management of AF TBD Leyva F. - Sutton Coldfield, GBR •  ow to Assess Responders in NYHA I-II Heart Failure H•  anagement of VAs (from PVCs to Sustained VT) M Patients? Mittal S. - New York City, USA Linde C. M. - Stockholm, SWE •  ow to Assess CRT Response in Non-Compliant Patients? H Gold M. - Charleston, USA •  re There Specific Criteria to Identify Super Responders A before and during Implantation? Reynolds D. W. - Oklahoma City, USA The platform to consult and free download ECG and Epidemiology data http://epdatabank.cardiostim.com www.cardiostim.com 39
    • Advance programPacing, ICDs and CRTPACING AND ICDWednesday June 13 / 11:00 - 12:30 Thursday June 14 / 09:00 - 10:30SHOULD WE IMPLANT THOSE PATIENTS? CHALLENGES OF ICD THERAPY - PART I:Chair: FUNCTIONING AND CHOICE OF THE DEVICERuffy R. - Salt Lake City, USA Chair:Sulke N. - Eastbourne, GBR Israel C.W. - Bielefeld, DEU Delnoy P.P. - Zwolle, NLD•  onduction Disorders after TAVI C Dos Santos P. - Bordeaux, FRA •  ive ICD Manufacturers: Specificities for Detection, F•  octurnal Bradycardia with and without Sleep Apnea N Discrimination and Therapies Nielsen J. C. - Aarhus, DNK Bordachar P. - Bordeaux, FRA•  rug-Induced Bradycardia D •  he Specific Features of the Different ICDs Available Influence T Adragao P. - Lisbon, PRT My Choice•  yotonic Dystrophy (Steinert Disease) M Ellenbogen K. - Richmond, USA Lazarus A. - Paris, FRA Cannom D. S. - Los Angeles, USA Thursday June 14 / 11:00 - 12:30 CHALLENGES OF ICD THERAPY - PART II: PROGRAMMING THE DEVICE Chair: Cannom D. S. - Los Angeles, USA Lubinski A. - Lodz, POL •  oung Patient with Normal Heart (Brugada, Long QT, Y Idiopathic VF) TBD • schemic Heart Disease & Primary Prevention I Mittal S. - New York City, USA •  oung Patient with Hypertrophic Cardiomyopathy (Obstructive Y and Non-Obstructive) Ellenbogen K. - Richmond, USA • mpact of Drugs on ICD Programming (Clinical Cases) I Klein H. - Rochester, USA40 www.cardiostim.com
    • Cardiostim 2012Pacing, ICDs and CRTThursday June 14 / 14:00 - 15:30 Friday June 15 / 09:00 - 10:30CHALLENGES OF ICD THERAPY - PART III: SUBCUTANEOUS ICDS: A PATH TO AMANAGEMENT OF ELECTRICAL STORMS AND TECHNOLOGICAL REVOLUTIONINAPPROPRIATE SHOCKS Chair:Chair: Borggrefe M. - Mannheim, DEUHayes D. - Rochester, USA Murgatroyd F. D. - Cambridge, GBRMabo P. - Rennes, FRA •  olerance of the Material and Efficacy of Arrhythmia Detection T•  rugs for Recurrent VAs in ICD Patients D Bardy G. H. - Seattle, USA Giudici M. - Davenport, USA •  ata Based on Clinical Studies D•  atheter Ablation in ICD Patients C Exner D. - Calgary, CAN Maury P. - Bordeaux, FRA •  Specific Population for SQ ICDs? A•  ecision Making Process for ICD Lead Change D Jordaens L. - Rotterdam, NLD Hauser R. - Long Lake, USA•  roken Lead in a System That Never Recorded VAs: Extract, B Replace or Remove Everything? Neuzil P. - Praha, CZEThursday June 14 / 16:00 - 17:30 Friday June 15 / 11:00 - 12:30CHALLENGES OF ICD THERAPY - PART IV: YOUR OPINIONDIFFICULT DECISIONS Chair:Chair: Ritter P. - Bordeaux, FRABinner L. - Ulm, DEU Reynolds D. W. - Oklahoma City, USAVarma N. - Cleveland, USA •  eadless ICD and Leadless Pacemaker L• CD for Elderly Patients: What Is the Limit and when Should I Wilkoff B. L. - Cleveland, USA We Consider ICD Deactivation? Brachmann J. - Coburg, DEU Hayes D. - Rochester, USA • mplantation of ICDs for Primary Prevention in Patients Older I•  riving for ICD Recipients: Where Are the International Rules? D than 80 Years Albert C. - Boston, USA Benditt D. G. - Minneapolis, USA Klein H. - Rochester, USA• CD Recipients at Work: Impact of Environment I TBD www.cardiostim.com 41
    • Advance programPacing, ICDs and CRTWednesday June 13 / 11:00 -12:30 Wednesday June 13 / 14:00 - 15:30ART OF TIMING (PART I) ART OF TIMING (PART II)Chair: Chair:Ronaszéki A. - Budapest, HUN Ronaszéki A. - Budapest, HUNChirife R. - Buenos Aires, ARG Chirife R. - Buenos Aires, ARG•  he Concept of Optimal AV Delay T •  ifferent Methods for Hemodynamic Optimization D Ronaszéki A. - Budapest, HUN Gold M. - Charleston, USA• mpact of Inter- and Intra-Atrial Conduction Delays on Optimal I •  ow Efficient Are the Automatic Features of Implantable H AV Interval Devices? Saksena S. - New Brunswick, USA Lunati M. - Milano, ITA•  hat Can We Learn from Computer Simulations of AV- and W •  ound Table: AVD and V-V Interval Optimization in CRT: How Is R VV-Delay Optimization? This Best Accomplished? Lumens J. - Maastricht, NDL Singh J. - Boston, USA•  ffect of Heart Rate and Exercise on Optimal AV Interval E Gold M. - Charleston, USA Israel C. W. - Bielefeld, DEU Lunati M. - Milano, ITA Abi-Samra F. M. - New Orleans, USA Subscribe to Cardiostim newsletter ✓ on www.cardiostim.com42 www.cardiostim.com
    • Cardiostim 2012Leads Pacing and ICD LeadsChair:J. Helland - Sylmar, USAWednesday June 13 / 14:00 - 15:30 Wednesday June 13 / 16:00 - 17:30WHAT ARE ENGINEERS DOING TO IMPROVE WHAT ARE PHYSICIANS LEARNING THATCARDIAC LEAD FUNCTION & RELIABILITY? NEEDS IMPROVEMENT IN CARDIAC LEADS?Chair: Chair:McVenes R. - Mounds View, USA Helland J. R. - Sylmar, USARicci R. - Rome, ITA Kennergren C. - Göteborg, SWE •  ulti-Electrode LV Leads: What Should the Electrode Spacing M•  hat New Standardized Testing of Leads Will Be W Be and Why? Implemented by Manufacturers: An AAMI CRMD Thibault B. - Montreal, CAN Cooke D. - St Paul, USA •  hen Transvenous LV Leads Won’t Work – EP Implantation W•  hat Does a Physician Extractor Need to Know about the W of Cardiac Leads in the Pericardial Space Design of Cardiac Leads? Jaïs P. - Bordeaux, FRA Marshall M. - Minneapolis, USA •  hat Improvements Are Needed in Lead Design and W•  linical Safety & Reliability Performance Update of DF4 C Materials to Reduce Patient Risk and Increase Reliability of Connector Systems Successful Extractions? Helland J. R. - Sylmar, USA Schaerf R. - Burbank, USA•  ow Does the Implant Technique & Location Affect the Forces H •  hat Is the Proper Way to Place the Device & Lead in the W & Stresses Applied to Implanted Leads? Pocket and to Anchor Lead Suture Sleeves and What Is Binner L. - Ulm, DEU Needed for the Future?•  hat Have Engineers Learned from Analyzing Force Loading W Skehan J. D. - Leicester, GBR and Use Conditions on Implanted Leads? •  hat Does a Physician Need to Consider When Using MRI W Baxter W. - Minneapolis, USA Safe Systems Regarding Lead Abandonment vs Extraction? Bongiorni M. G. - Pisa, ITA www.cardiostim.com 43
    • Advance programLeads Lead ManagementOrganized byKennergren C. - Göteborg, SWEWednesday June 13 / 14:00 - 15:30 Thursday June 14 / 09:00 - 10:30CIED PATIENT INFECTION LEAD MANAGEMENTChair: Chair:Wilkoff B. L. - Cleveland, USA Epstein L. - Boston, USANeuzil P. - Praha, CZE Bongiorni M. G. - Pisa, ITA•  hat Leads Should/Should Not Be Removed According to W •  ategories, Incidences, Causes and Outcomes C EHRA and HRS Recommendations? Bracke F. - NLD Deharo J. C. - Marseille, FRA •  iagnosis, Pharmacological Treatment and Timing of D•  hat Are the Present Results of Lead Extraction in High, W Extraction Medium and Low Volume Centers? Blum T. - Bad Krozingen, DEU Pelargonio G. - ITA •  ransvenous Extraction, Surgical Extraction and Local T•  anagement of Superfluous Leads; Should All Superfluous M Revision Leads Be Extracted? Fischer A. - USA Butter C. - Bernau, DEU •  iming of Re-Implantation and Treatment of PM Dependent T•  anagement of Recalled Leads; What Leads in Which M Defaye P. - Grenoble, FRA Patients Should and Should Not Be Extracted? Birgersdotter Green U. - San Diego, USA Thursday June 14 / 14:00 - 15:30 PERFORMING LEAD EXTRACTION Chair: Klug D. - Lille, FRA •  raining and Site Requirements T Mitkowsky P. - Poznan, POL •  ransvenous Lead Extraction from the Route of Implantation; T Available Techniques Rinaldi A. - London, GBR •  emoral, Transjugular, Surgical, Hybrid and Other Non F Standard Lead Extraction Techniques Love C. - Columbus, USA •  reatment of Lead Extraction Complications T Kennergren C. - Göteborg, SWE44 www.cardiostim.com
    • Cardiostim 2012Associate SymposiaCardiostim/HRS Joint Session Vaso Vagal Syncope Organized byFriday June 15 / 09:00 - 10:30 Blanc J. J. - Brest, FRATHE 2012 HRS / EHRA / ECAS CONSENSUS Thursday June 14 / 11:00 - 12:30DOCUMENT ON CATHETER AND SURGICALABLATION OF ATRIAL FIBRILLATION VASO VAGAL SYNCOPE: THERE ARE NEWChair: DATA!Calkins H. - Baltimore, USA Chair: Alboni P. - Ferrara, ITA• ntroduction and Overview of the Recommendations I Sutton R. - Monte-Carlo, MCO Calkins H. - Baltimore, USA •  hat Is Vaso Vagal Syncope: Physiopathology, Genetics and W•  trategies for Anticoagulation: What Does the Consensus S Diagnosis? Document Tell Us? Benditt D. G. - Minneapolis, USA DiMarco J., USA •  aso Vagal Reactions in Animals to Vaso Vagal Syncope in V• mplications for the Design of Clinical Trials of AF Ablation I Humans: Identical or Different? Packer D. L. - Rochester, USA Blanc J. J. - Brest, FRA•  uidelines from Around the World: How Do They Compare? G •  hen and How to Treat Vaso Vagal Syncope (Except by W Gillis A. M. - Calgary, CAN Pacing)? Ammirati F. - Roma, ITA •  acing in Vaso Vagal Syncope: From VPS I to ISSUE III PCardiopace Brignole M. - Lavagna, ITAOrganized byJazra C. - Beirut, LBNWednesday June 14 / 16:00 - 17:30LVH AND SUDDEN DEATH: FROMCLASSIFICATION TO MANAGEMENTChair:Al Fayyad M. - KSAKhoury M. - Beirut, LBN•  cho versus ECG Classification of LVH E Chamams E. - Beirut, LBN•  echanism of Arrhythmia in Patients with LVH M Oto A. - Ankara, TUR•  isk Assessment: What Do the Guidelines Tell Us? R Veltmann C. - DEU•  ypertension and LVH: Determinants of Risk H Jazra C. - Beirut, LBN www.cardiostim.com 45
    • Advance programAssociate SymposiaGeriatric CardiologyOrganized byShen W. - Scottsdale, USAVlietstra R.E. - Lakeland, USAMunger Thomas T. - Rochester, USA ARRHYTHMIA MANAGEMENT IN OLDER PERSONS WITH A FOCUS ON CASE BASED DISCUSSIONThursday June 14 / 09:00 - 10:30 Thursday June 14 / 11:00 - 12:30FAINTING AND FALLS: HOW CAN WE ATRIAL FIBRILLATION & STROKE PREVENTION:MAINTAIN THE UPRIGHT POSITION AS WE GET NEW TECHNIQUES, NEW TECHNOLOGY, NEWOLDER? ANTICOAGULANTS & NEW DRUGS FOR THEChair: ELDERLYBenditt D. G. - Minneapolis, USA Chair:Raviele A. - Venice, ITA Gaita F. - Torino, ITA Munger T. - Rochester, USA•  tate-of-the-Art Lecture: Aging and Autonomic Regulation: S Physiology and Clinical Relevance • State-of-the-Art Lecture: AF in the Elderly: Drugs, Ablation Low P. - Rochester, USA and DevicesCase Presentation and Panel Discussion Calkins H. - Baltimore, USA•  ASE 1: 84 yr W, Diabetic w/ Parkinson’s & recurrent C C  ase Presentation and Panel Discussion syncope •  ase 1: 86 yr W, HTN, Diabetic w/ 2 recurrent TIAs in setting C TBD of PAF, GI bleeds/falls•  ASE 2: 88 yr M, dementia, LBBB, 1 year H/O recurrent C Friedman P. - Rochester, USA syncope •  ase 2: 90 yr M, persistent AF, HTN, CHF, and COPD C Parry S. W. - New Castle, GBR Shen W. - Scottsdale, USA•  ASE 3: 87 yr M, anemia, EF 30%, palpitations & near C •  ase 3: 85 yr retired surgeon runs marathon, sinus C syncope x 2 bradycardia and symptomatic PAF TBD Hocini M. - Bordeaux, FRA46 www.cardiostim.com
    • Cardiostim 2012Associate SymposiaThursday June 14 / 14:00 - 15:30 Thursday June 14 / 16:00 - 17:30PACEMAKER & ICD: WHEN DO WE SAY YES HEART FAILURE AND CARDIAC IMAGING:AND WHEN DO WE SAY NO? SPECIAL CONSIDERATIONS AND RELEVANTChair: ISSUES IN THE ELDERLYHammill S. - Rochester, USA Chair:Gillis A. M. - Calgary, CAN Vlietstra R. - Lakeland, USA Wilkoff B. - Cleveland, USA•  tate-of-the-Art Lecture: Pacemaker and ICD: Implantation, S Withhold and Withdraw Therapy •  tate-of-the-Art Lecture: Heart Failure in the Elderly: S TBD Knowledge Gaps in CRTCase Presentation and Panel Discussion TBD•  ASE 1: 82 yr M, CAD, prior EF 32%, NYHA III, NSTEMI 3 C Case Presentation and Panel Discussion days ago, SR 34 bpm, EF 30% •  ASE 1: 83 yr M, prior MI NYHA III CHF, COPD, QRS duration C Cha Y-M. - Rochester, USA 120 ms, Echo EF 30%•  ASE 2: 89 yr W, independent, DCM, NYHA II, EF 25%, not C Lee H-C. - Rochester, USA PM dependent, ICD at ERI •  ASE 2: 88 yr W, renovascular HTN, PVCs, Sestamibi EF C Jahangir A. - Milwaukee, USA 60%, NYHA III CHF symptoms•  ASE 3: 92 yr W, PAF, daytime pauses of 4.2 seconds, EF C Zieman S. - Bethesda, USA 55%, no symptoms •  ASE 3: 86 yr W, DOE on golf course, EF 48%, dense LMCA/ C Srivathsan K. - Scottsdale, USA LAD CA++, elevated BNP Behrenbeck T. - Rochester, USA www.cardiostim.com 47
    • Advance programAssociate SymposiaAsia Pacific Cardiostim Symposium PalpitationsUnder the Auspices of the Asia Pacific Society Organized byof Cardiology Raviele A. - Venice, ITAOrganized bySethi K. - New Delhi, IND Friday June 15 / 09:00 - 10:30Vohra J. - Melbourne, AUSSloman G. - Richmond, AUS MANAGEMENT OF PATIENTS WITH PALPITATIONSFriday June 15 / 09:00 - 10:30 Chair: Prystowsky E. - Indianapolis, USAMANAGEMENT OF ARRHYTHMIAS IN THE Raviele A. - Venice, ITAELDERLY IN THE ASIAN PACIFIC REGIONChair: •  efinition, Causes and Classifications DS loman G. - Richmond, AUS Steinbeck G. - Munchen, DEUVohra J. K. - Melbourne, AUS •  iagnosis Strategy and Clinical Evaluation D Blanc J. J. - Brest, FRA•  on-Ischaemic Ventricular Tachycardia in Asia Pacific: N •  mbulatory Electrocardiographic Monitoring A Regional Variation Giada F. - Noale, ITA Sethi K. - New Delhi, IND •  lectrophysiologic Study and Other Instrumental Investigations E•  atheter Ablation of Ventricular Tachycardia in Hypertrophic C Blomstrom-Lundqvist C. - Uppsula, SWE Cardiomyopathy and Sarcoidosis Soejima K. - Kawasaki, JPN •  ow to Treat and When to Hospitalize H Viskin S. - Tel Aviv, ISR•  atheter Ablation of Unusual Outflow Ventricular Tachycardia C Kantharia B. - Columbus, USA•  urgical Ablation of Non-Ischemic Ventricular Tachycardia S Nitta T. - Tokyo, JPN48 www.cardiostim.com
    • Cardiostim 2012Associate SymposiaFetal Cardiology Symposium Thursday June 14 / 14:00 - 15:30Organized by FETAL ARRHYTHMIAS - PART IIGuirgis M. - Paris, FRA Chair: Silverman N. - USAThursday June 14 / 11:00 - 12:30 Cuneo B. - Chicago, USABASIC UNDERSTANDING AND EXPLORATION •  itfalls in Fetal Rhythm Diagnosis POF FETAL RHYTHM Blom N. - Leiden, NDLChair: •  etal Therapy : Medical and Ethical Basis FGuirgis M. - Paris, FRA Guirgis M. - Paris, FRASquarcia U. - Parma, ITA •  reatment Strategies of Fetal Tachyarrhythmias T Hornberger L.K. - Edmonton, CAN•  ormal Development of Conductive System and Regulation of N •  urrent Management of Auto Immune Av Block C Fetal Rhythm: Substrate for Fetal Arrhythmias Jaeggi E. - CAN Blom N. - Leiden, NDL •  he Cardiac Fetus at Risk of Sudden Death T•  lassic and New Techniques in Evaluation of Fetal Rhythm C Cuneo B. - Chicago, USA Cuneo B. - Chicago, USA•  elemedicine Role in Fetal Cardiology T Cuneo B. - Chicago, USA PRACTICAL INTERACTIVE WORKSHOPThursday June 14 / 14:00 - 15:30 Chair: Jaeggi E. - CANFETAL ARRHYTHMIAS - PART I Hornberger L.K. - Edmonton, CANChair: LIVE DEMONSTATIONS OF ECHODOPPLER TECHNICS FORHornberger L.K. - Edmonton, CAN ANALYSIS OF FETAL RHYTHMJaeggi E. - CAN•  pdate in Genetics Studies of Fetal Arrhythmias U Priori S.G. - Pavia, ITA•  iagnosis of Fetal Tachyarrhythmias D Hornberger L.K. - Edmonton, CAN•  iagnosis of Fetal Bradycardias D Jaeggi E. - CAN•  ow to Suspect Long QT in a Fetus? H Cuneo B. - Chicago, USA•  etal heart failure in fetal arrhythmias: Mechanisms and F echocardiographic presentations Silverman N. - USA www.cardiostim.com 49
    • Advance programAssociate SymposiaPediatric Cardiac ElectrophysiologyOrganized byThambo J.B. - Bordeaux, FRAThursday June 14 / 09:00 - 10:30 Thursday June 14 / 14:00 - 15:30PITTFALLS AND PEARLS… VENTRICULAR ARRYHTHMIAS AND SUDDEN•  PW and Supraventricular Tachycardia W DEATH IN CONGENITAL HEART DISEASE: Ernst S. - Hamburg, DEU CHALLENGES AND CREATIVE SOLUTIONS•  rrhythmias and Grown-Ups with Congenital Heart Defect A Chair: Hebe J. - DEU Khairy P. - USA•  bnormal EKG or Not A TBD •  isk Stratification for VT and Sudden Death in Congenital R Heart Disease: When to Worry? Abadir S. - USAThursday June 14 / 11:00 - 12:30 •  ptimizing ICD Programming In Congenital Heart Disease OHOT TOPIC IN PEDIATRIC PACING Mansour F. - USA•  ediatric Pacing 30 Years after P •  T Ablation in Congenital Heart Disease: Lessons Learned V Silvetti M. - Milano, ITA from Acquired Heart Disease•  lternative Approaches in Patients with Congenital Heart A Sacher F. - Bordeaux, FRA Disease Bordachar P. - Bordeaux, FRA•  re There Indications for Prophylactic Leads Extraction in A Cardiostim – Japanese Heart Rhythm Society Pediatric Patient? (JHRS) Joint Symposium Hidden Lucet F. - Paris, FRA Chair: Nakazato Y. - Tokyo, JPNThursday June 14 / 11:00 - 12:30 Cazeau S. - Paris, FRACHANNELOPATHY IN PEDIATRICS: CASE Friday June 15 / 11:00 – 12:30REPORT, EKG •  hysiology of the Failing Heart P•  rugada Syndrome B TBD Brugada P. - Aalst, BEL •  arrow QRS Patients: Is the Story Over? N•  ong QT Syndrome L Anselme F. - Rouen, FRA Wilde A. M. - Amsterdam Zuidoost, NLD •  blation of the Benign VT? A• CD in Pediatrics I Uno K. - Tokyo, JPN Berul C. - Washington USA •  rugada Syndrome Management - The Japanese Position B Takagi M. - Osaka, JPN50 www.cardiostim.com
    • Cardiostim 2012Associate SymposiaSyncope ICE ProgramOrganized by Organized byFlammang D. - Lyon, FRA Saksena S. - Warren, USAFriday June 15 / 11:00 - 12:30 Thursday June 14 / 09:00 - 10:30UNDERSTANDING SYNCOPE INNOVATIONS IN INTRACARDIACChair: ECHOCARDIOGRAPHY: NOVEL APPLICATIONSKenny R. A. - Dublin, IRL AND EVIDENCE BASED EVALUATIONFlammang D. - Lyon, FRA Chair: Saksena S. - Warren, USA•  europhysiology of TLOC: Syncope and Non-Syncope N Ryvlin P. - Lyon, FRA • mportance and Limitations of Imaging Techniques in Left I•  hysiopathology of CSM P Ventricular Lead Placement For Cardiac Resynchronization Parry S. W. - Newcastle Upon Tyne, GBR Desai M. - Cleveland, USA•  yncope and Channellopathies S •  dvances in ICE Based Analyses of Left Ventricular Function A Abi-Samra F. M. - New Orleans, USA Di Biase L. - Austin, USA•  ew Research Pathways in Syncope N • CE Guided CRT: Design and Implications of an Evidence I Benditt D. G. - Minneapolis, USA Based Approach – The CHOICE Study•  est in the Management of Syncope: Basic Aspects of Data T Saksena S. - Warren, USA Interpretation •  eft Atrium and Appendage Imaging with ICE: Technologic L Pelleg A. - Philadelphia, USA Advances and Unconventional Approaches Liu C. F. - New York, USA • CE Guided Cardioversion: Are We Ready for Clinical Trials? IFriday June 15 / 14:00 - 15:30 Jordaens L. - Rotterdam, NLDCLINICAL CASES ON SYNCOPEChair:Parry S. W. - Newcastle Upon Tyne, GBRBlanc J. J. - Brest, FRA•  LINICAL CASES C Parry S. W. - Newcastle Upon Tyne, GBR Benditt D. G. - Minneapolis, USA Pruvot E. - Lausanne, CHE Flammang D. - Lyon, FRA Deharo J. C. - Marseille, FRA Blanc J. J. - Brest, FRA www.cardiostim.com 51
    • Advance programAssociate SymposiaItalian Cardiostim Symposium EPIC AllianceOrganized bySantomauro M. - Naples, ITA The EPIC Alliance is designed to provide global networking,Friday June 15 / 14:00 - 15:30 professional development, and exclusive research opportunities for female Electrophysiologists.SPORT PRACTICE IN PACEMAKER AND ICDPATIENTSChair: The vision of the EPIC Alliance is to enrich and diversify the fieldBongiorni M. G. - Pisa, ITA of Electrophysiology by building a global network of women Electrophysiologists at all level of experience that will create a•  pdate on Prevention of Dangerous Leads in the Athletes with U community of collaboration, mainly by mentoring. It provides Pacemaker peer information on how to balance personal and professional Delise P. - Conegliano Veneto, ITA issues, offers opportunities for clinical research projects and•  pdate on Prevention of Dangerous XXX in the Athletes with ICD U enables leadership and career development. Padeletti L. - Firenze, ITA•  ommotio Cordis in Young Athletes: How to Prevent It? C Friday June 15 / 14:00 - 15:30 Gaita F. - Asti, ITA•  udden Death in Athletes: The Role of the PM and the ICD S EP: WHAT’S HOT, WHAT’S NOT, WHAT’S TOUGH Lunati M. - Milano, ITA Chair:•  anagement of the Syncope in Athletes with Implantable Devices M Poole J. E. - Washington, USA Inama G. - Crema, ITA Hoffmann E. - Munchen, DEUFriday June 15 / 14:00 - 15:30 •  F Ablation: Beyond Pulmonary Vein Isolation – Case studies A Ernst S. - London, GBRSUDDEN DEATH IN HOSPITAL AND OUT OF Eisenberg S. - Walnut Creek, USAHOSPITAL: NEW AUTOMATIC EXTERNAL •  ontroversies in Lead Extractions for Non-Infectious CDEFIBRILLATION ON-LINE IndicationsChair: Birgersdotter- Green U. - San Diego, USAGulizia M. - Catania, ITA Bongiorni M. G. - Pisa, ITASantomauro M. - Napoli, ITA •  omplex VT Ablation: When the Going Gets Tough C Chung M. - Cleveland, USA•  he Network of AED in Hospital T Blomström-Lundqvist C. - Upsala, SWE Cappato R. - San Donato Milanese, ITA •  iscussion / Q&A D•  ED in Hospital: The Impact of the 2010 ILCOR Guidelines A Montenero A. - Sesto San Giovanni (Milan), ITA•  pplicability of New AEDs on Line during Sports Events A Giada F. - Noale, ITA•  ost/Effectiveness of AEDs on Public Use C Capucci A. - Ancona, ITA•  AD Projects: Practical Training of First Responders P Roscio G. - Roma, ITA•  egal Issue on Public Use of AEDs with Remote Monitoring L Riganti C. - Napoli, ITA52 www.cardiostim.com
    • Cardiostim 2012Industry SymposiaThursday June 14 / 14:00 - 15:30 Friday June 15 / 11:00 - 12:30NEW ADVANCES FOR PATIENTS WITH ATRIAL LAA CLOSURE FOR STROKE PREVENTION:FIBRILLATION WHAT EVERY ELECTROPHYSIOLOGIST SHOULDChair: KNOWCamm A. J. - London, GBR Moderators:Hindricks G. - Leipzig, DEU Camm A. J. - London, GBR Schumacher B. - Bad Neustadt/sale, DEU• mpact from Remote Monitoring on Anticoagulation I Ip J. - Lansing, USA • s There a Room for a Device Alternative to Oral I•  ays to Reduce Inappropriate ICD Therapies in AF W Anticoagulants (OAT) ? Bänsch D. - Rostock, DEU Camm A. J. - London, GBR•  ow to Achieve Reliable Cardiac Resynchronization in AF? H •  AAC with WATCHMANTM Device: Latest Clinical Evidences L Gras D. - Nantes, FRA •  ATCHMAN: A Clinically Proven Therapy W• mproving the Outcome of AF Ablation I Reddy V. Y. - Boston, USA Kuck K. H. - Hamburg, DEU •  atient Selection: Finding the Right Patient in the Right Place P Session made possible thanks to an educational grant from Schumacher B. - Bad Neustadt, DEU BIOTRONIK •  AAC Implant: Practicing Our Knowledge on Real Cases L Reddy V. Y. - Boston, USA •  ebate: LAAC & AFIB Ablation - Should We Perform Both D Simultaneously?Thursday June 14 / 14:00 - 15:30 Pro: Boersma L. - Nieuwegein, NLDTHE SUBCUTANEOUS ICD Contra: Schmidt B. - Hamburg, DEUChair: Session made possible thanks to an educational grant fromWilkoff B. L. - Cleveland, USA BOSTON SCIENTIFICKlein H. - Rochester, USA•  verview of the S-ICD System O Cappato R. - San Donato Milanese (MI), ITA•  esults of the S-ICD System’s IDE Study R Gold M. D. - Charleston, USA•  FFORTLESS – The First Results E Boersma L. - Nieuwegein, NLD•  he Future of ICD Therapy T Morgan J. M. - Southampton, GBR Session made possible thanks to an educational grant from CAMERON HEALTH www.cardiostim.com 53
    • Advance programIndustry SymposiaWednesday June 13 / 11:00 - 12:30 Wednesday June 13 / 16:00 - 17:30DIAGNOSING AF: CAN WE PREVENT STROKES EMERGING LEADERS IN ELECTROPHYSIOLOGY:CAUSED BY AF? CASE PRESENTATION AND DISCUSSIONChair: Chair:Krieger D. - Copenhagen, DNK Prystowsky E. N. - Indianapolis, USAHohnloser S. - Frankfurt, DEU •  aculty F•  ore Intensive Monitoring Leads to More AF Detection M Schalij M. - Leiden, NLD Wachter R. - Göttingen, DEU Priori S. G. - Pavia, ITA•  F Burden Is a Determinant Risk Factor for Stroke A Borggrefe M. - Mannheim, DEU Boriani G. - Bologna, ITA •  ase Report 1 C•  ryptogenic Stroke: Why Move Beyond the Guidelines? C Bianchi S. - Roma, ITA Cotter P. - Cambridge, GBR •  ase Report 2 C•  creening High Risk Patients for AF through Continuous S Thomas D. - Heidelberg, DEU Monitoring •  ase Report 3 C Heinzel F. - Graz, AUT Duparc A. - Toulouse, FRA Session made possible thanks to an educational grant from •  ase Report 4 C MEDTRONIC Brown B. - Manchester, GBR Session made possible thanks to an educational grant from MEDTRONICWednesday June 13 / 14:00 - 15:30TREATING AF: HOW TO EFFECTIVELY REDUCESTROKE RISK?Chair:Kirchhof P. - Birmingham, GBRDiener H.C. - Essen, DEU•  troke Prevention from the Cardiologist‘s Perspective S Camm A. J. - London, GBR•  hat We Need to Know about Strokes Caused by AF W Thijs V. - Leuven, BEL•  ew Drugs for Stroke Prevention N Huber K. - Vienna, AUT•  arly PVI as a Treatment Option after Stroke Caused by AF E Tondo C. - Milano, ITA•  uture Strategies for Device Therapy in AF Management F Hill M. - Minneapolis, USA Session made possible thanks to an educational grant from MEDTRONIC54 www.cardiostim.com
    • Cardiostim 2012Industry SymposiaThursday June 14 / 11:00 12:30 Thursday June 14 / 14:00 - 15:30HOW TO INCREASE CRT RESPONSE? PULMONARY VEIN ISOLATION: THEChair: CORNERSTONE OF ATRIAL FIBRILLATIONGras D. - Nantes, FRA ABLATIONCurnis A. - Brescia, ITA Chair: Furniss S. - Eastbourne, GBR•  efining CRT Response D Blomstrom-Lundqvist C. - Uppsula, SWE Leclercq C. - Rennes, FRA•  ew Tools to Position the LV Lead at the Point of Latest N •  echniques for Catheter Ablation of Paroxysmal and T Activation Persistent Atrial Fibrillation: A Systematic Review Cantu F. - Bergamo, ITA Verma A. - New Market, CAN•  ontinuous Automatic Adaptation of the AV and VV Interval C •  ryoballoon Ablation of Pulmonary Veins: Global Clinical C Milasinovic G. - Belgrade, SRB Experience•  are Pathway of HF Patients: Improving Efficiency C Neumann T. - Bad Nauheim, DEU Wright J. - Liverpool, GBR •  uty Cycled Phased RF: Global Clinical Experience and D Session made possible thanks to an educational grant from Evolution MEDTRONIC Geller C. - Bad Berka, DEU •  omparing Technologies: What Are the Impacts of Energy C Source on Results? Schilling R. - London, GBR •  arly Ablation: Should Cryoballoon Ablation Be Proposed as E First-Line Therapy? Chierchia G. - Brussels, BEL Session made possible thanks to an educational grant from MEDTRONIC www.cardiostim.com 55
    • Advance programIndustry SymposiaFriday June 15 / 09:00 - 10:30 Friday June 15 / 11:00 - 12:30ICD THERAPY SAVES LIVES: DO YOU CARE? NEW ADVANCES IN TREATMENT OFChair: PACEMAKER PATIENTSvan Gelder I. C. - Groningen, NLD Chair:Kacet S. - Lille, FRA Sperzel J. - Bad Nauheim, DEU Sutton R. - Monte-Carlo, MCO•  hy Should We Care Implanting ICDs? W Auricchio A. - Lugano, CHE •  acemaker Therapy in Vasovagal Syncope: ISSUE III Study P•  conomics of ICD Therapy: Limitations of Cost Efficacy E Results Braunschweig F. - Stockholm, SWE Brignole M. - Lavagna, ITA•  ole of Discrimination Algorithms to Prevent Inappropriate R •  xperience with MRI Safe Devices E Shocks Weishaupt D. - Zurich, CHE Gold M. - Charleston, USA •  he Importance of Device Detected Atrial Fibrillation T•  ew Solutions to Increase Benefits and Reduce Risks N Santini M. - Roma, ITA Gasparini M. - Rozzano (MI), ITA •  he Role of New Technology in Device Follow-Up T• nnovative Tools to Improve Patient’s and Physician’s Lives I Morgan J. M. - Southampton, GBR Mason M. - Harefield, GBR •  he Future of Bradycardia Pacing: Leadless Pacemakers T Session made possible thanks to an educational grant from Ritter P. - Bordeaux, FRA MEDTRONIC Session made possible thanks to an educational grant from MEDTRONICThursday June 14 / 9:00 - 10:30RAPID MAPPING AND CRT OPTIMIZATION WITH NONINVASIVE 3D ELECTROCARDIOGRAPHY:A NEW ERA!Mapping Chair: Haïssaguerre M. - Bordeaux, FRACRT Chair: Singh J. - Boston, USA•  ccurate Single Beat Mapping and Ablation of Premature Ventricular Beats A Kanagaratnam P. - London, GBR•  apid Mapping of Focal Ventricular Arrhythmias – A Prospective Multi-Centric Evaluation R Neumann T. - Bad Nauheim, DEU•  lectrical Synchrony: A Powerful Tool for Selection, Implantation and Optimization of CRT E Ritter P. - Bordeaux, FRA•  linical Validation of Non-Invasive Electrocardiographic Mapping of Arrhythmias: A Multi-Center Experience C Lindsay B. - Cleveland, USA Session made possible thanks to an educational grant from CARDIOINSIGHT TECHNOLOGIES56 www.cardiostim.com
    • Cardiostim 2012Industry SymposiaWednesday June 13 / 11:00 - 12:30 Thursday June 14 / 09:00 - 10:30INNOVATION IN EP- ADDING NEW VALUES: STATE-OF-THE-ART HF MANAGEMENT: FROMCLINICAL APPROACHES AND THE LAB OF THE IMPLANT TO LONG-TERM FOLLOW-UPFUTURE•  ecorded MediGuide Case with Velocity Integration from R •  he Future of CRT Therapy : Addressing Common Pacing T Cotignola Complications and Minimizing Fluoro Exposure•  ocus on Mediguide EP & CRM Tools F • mproving CRT Response : Optimizing CRT Pacing and I•  ediGuide in Everyday Use M Assessment of Multipoint Pacing Session made possible thanks to an educational grant from •  dvancement of HF Management : On the Cutting Edge A ST JUDE MEDICAL Session made possible thanks to an educational grant from ST JUDE MEDICALWednesday June 13 / 16:00 - 17:30 Thursday June 14 / 16:00 - 17:30St Jude Medical MEA EVERYTHING AND MRI: IS IT FOR EVERYBODY?Chair: •  RI & Medical Devices: Current Status MAl-Fagih A. - Riyadh, SAU •  ew Pacemaker Generations and MRI – Current Status NCurnis A. - Brescia, ITA • CD’s and MRI, Is This Really MRI Conditional? IJazra C. - Beirut, LBN •  eadless Pacing – A Glimpse in the Future L•  rrhythmia in ME: From Incidence to Solution A Session made possible thanks to an educational grant from•  he Evolving Landscape of Electrophysiology Services: T ST JUDE MEDICAL Challenges and Opportunities•  acemaker Evolution: From Standard VVI to MRI Compatible P•  hat’s New in CRT: The Other Two Electrodes W•  fib Ablation: Usage of Different Technology for Complex A Arrhythmia Session made possible thanks to an educational grant from ST JUDE MEDICAL www.cardiostim.com 57
    • Advance programIndustry SymposiaWednesday June 13 / 14:00 - 15:30 Thursday June 14 / 16:00 - 17:30THE ROLE OF CARDIOLOGISTS IN SLEEP THE IMPORTANCE OF CRT OPTIMIZATIONAPNEA MANAGEMENT IN DAILY LIFE: ADDRESSING THE CHANGINGChair: PATIENT NEEDHayes D. - Rochester, USA Chair:Garrigue S. - Bordeaux, FRA Dickstein K. - Stavanger, NOR Padeletti L. - Firenze, ITA•  hy Should Cardiologists Now Be Alert to Sleep Apnea? W Darrel F. - London, GBR •  ncountering Reverse Remodeling and Changing Patient E•  revalence and Mechanisms of Sleep Apnea Syndrome P Status: The Need for More Regular Optimization Skowasch D. - Bonn, DEU Sadoul N. - Nancy, FRA•  ontribution of Pacemaker Sensors to Provide Apnea / C •  RT Optimization to Improve Clinical Response: From CLEAR C Hypopnea Index to RESPOND Trials Defaye P. - Grenoble, FRA Singh J - Boston, USA•  ow Can Cardiologists Better Manage Sleep Apnea Patients? H •  ase Presentation: Automatic Optimization of CRT Timing C Bordier P. - Bordeaux, FRA Oliveira M. - Lisbon, PRT•  ound Table Discussion R •  ase Presentation: Adapting CRT Settings to Patient Activity C Session made possible thanks to an educational grant from Mansourati J. - Brest, FRA SORIN GROUP •  ound Table Discussion R Session made possible thanks to an educational grant from SORIN GROUP Friday June 15 / 09:00 - 10:30 LASER LEAD EXTRACTION: MOVING TO THE NEXT LEVEL Session made possible thanks to an educational grant from SPECTRANETICS58 www.cardiostim.com
    • Cardiostim 2012Symposium STIMUPRATOrganisé parPierre Bordachar - CHU de Bordeaux, FRAStéphane Garrigue - Bordeaux, FRASylvain Reuter - Bordeaux, FRAPhilippe Ritter - CHU de Bordeaux, FRAFrédéric Sacher - CHU de Bordeaux, FRACe symposium est composé de 5 sessions présentées en français, à l’initiative de l’équipe bordelaise et selon une formule à succèsdéjà proposée en région Aquitaine depuis quelques années.Ce symposium non sponsorisé sera accrédité par la Société Française de Cardiologie. L’objectif est d’expliquer de façon didactiquele fonctionnement des prothèses cardiaques actives à partir de tracés électrocardiographiques et d’électrogrammes mémorisés, enutilisant directement en salle de conférence les programmateurs des différentes marques disponibles.Le but est de travailler en live comme à la consultation, à partir de documents réels présentés selon un ordre logique et illustrant lessituations les plus souvent rencontrées en stimulation cardiaque, défibrillation implantable et resynchronisation.Une des 5 sessions est dédiée à des dossiers complexes associant les diverses thérapeutiques d’électrophysiologie chez les mêmespatients. La participation de tous est nécessaire afin d’enrichir les discussions que les organisateurs souhaitent transformer en staffsplus qu’en présentations formelles.This non-sponsored symposium is composed of 5 sessions accredited by the French Society of Cardiology and will be given in French.Its objective is to explain the functioning of pacemakers, ICDs, and CRT devices from ECGs, and EGMs, using, -in the conferenceroom-- the programmers of the 5 companies available. Presentations should rather become a staff discussion, meaning the activeparticipation of attendees!Vendredi 15 juin / 11:00 - 12:30 Vendredi 15 juin / 14:00 - 15:30LES THERAPIES HYBRIDES : PROTHESE LA CONSULTATION EN LIVE :IMPLANTABLE + ABLATION + MEDICAMENTS FONCTIONNEMENT DES DEFIBRILLATEURS+ … DU CABINET A LA SALLE AUTOMATIQUES IMPLANTABLES A PARTIRD’ELECTROPHYSIOLOGIE DES PROGRAMMATEURS (D’UNE MARQUE AModérateurs : L’AUTRE)Frédéric Sacher - CHU de Bordeaux, FRA Modérateurs :Mark O’Neill - London, GBR Pierre Bordachar - CHU de Bordeaux, FRASerge Boveda - Toulouse, FRA Stéphane Garrigue - Bordeaux, FRAPascal Defaye - Grenoble, FRA Sylvain Reuter - Bordeaux, FRAStéphane Garrigue - Bordeaux, FRA Philippe Ritter - CHU de Bordeaux, FRASylvain Reuter - Bordeaux, FRA Frédéric Anselme - Rouen, FRA Serge Boveda - Toulouse, FRA Pascal Defaye - Grenoble, FRA Nicolas Sadoul - Nancy, FRA www.cardiostim.com 59
    • Advance programSymposium STIMUPRATVendredi 15 juin / 16:00 - 17:30 Samedi 16 juin / 09:00 - 10:30LA CONSULTATION EN LIVE : LA CONSULTATION EN LIVE :FONCTIONNEMENT DES DEFIBRILLATEURS FONCTIONNEMENT DES STIMULATEURSAUTOMATIQUES IMPLANTABLES A PARTIR CARDIAQUES ET TOUT CE QUE VOUS AVEZDES PROGRAMMATEURS (D’UNE MARQUE A OUBLIE !L’AUTRE) Modérateurs :Modérateurs : Pierre Bordachar - CHU de Bordeaux, FRAPierre Bordachar - CHU de Bordeaux, FRA Stéphane Garrigue - Bordeaux, FRAStéphane Garrigue - Bordeaux, FRA Sylvain Reuter - Bordeaux, FRASylvain Reuter - Bordeaux, FRA Philippe Ritter - CHU de Bordeaux, FRAPhilippe Ritter - CHU de Bordeaux, FRA Frédéric Sacher - CHU de Bordeaux, FRAFrédéric Anselme - Rouen, FRA Frédéric Anselme - Rouen, FRASerge Boveda - Toulouse, FRA Serge Boveda - Toulouse, FRAPascal Defaye - Grenoble, FRA Pascal Defaye - Grenoble, FRANicolas Sadoul - Nancy, FRA Daniel Gras - Nantes, FRA Samedi 16 juin / 11:00 - 12:30 LA CONSULTATION EN LIVE : DEMARCHE DIAGNOSTIQUE ET THERAPEUTIQUE CHEZ LE PATIENT STIMULE ET SYMPTOMATIQUE (DOULEUR THORACIQUE, DYSPNEE, PALPITATIONS, MALAISE, SYNCOPE) Modérateurs : Pierre Bordachar - CHU de Bordeaux, FRA Stéphane Garrigue - Bordeaux, FRA Sylvain Reuter - Bordeaux, FRA Philippe Ritter - CHU de Bordeaux, FRA Frédéric Anselme - Rouen, FRA Serge Boveda - Toulouse, FRA Pascal Defaye - Grenoble, FRA Daniel Gras - Nantes, FRA60 www.cardiostim.com
    • Cardiostim 2012PartnersPress partners www.cardiacrhythmnews.com www.karger.ch www.cardiologyjournal.orgwww.congenitalcardiologytoday.com www.elsevier.com www.hospimedica.com www.ipej.org www.ihe-online.com www.neonatologytoday.net www.oxfordjournals.org www.crc.springer.de www.theheart.org www.touchcardiology.com www.onlinelibrary.wiley.comSocieties partners Croatia Society of Cardiology Danish Society of Cardiology German Cardiac Society www.kardio.cr www.cardio.dk www.dgk.com Society of Cardiology Polish Cardiac Society Portuguese Society of Cardiology of the Russian Federation www.ptkardio.pl www.spc.pt/spc/ www.cardiosite.ru www.cardiostim.com 61
    • Advance programGeneral Information Scientific Organization GENERAL ORGANIZATION Chairman Managing Director Director Healthcare Division Dr Philippe Ritter Michel Filzi Laurence Gaborieau Phone: +33 (0)1 47 56 52 97 Phone: +33 (0)1 47 56 21 77 Scientific Coordinator michel.filzi@reedexpo.fr laurence.gaborieau@reedexpo.fr Jocelyne Toulouse Phone: +33 (0)1 47 56 24 56 Fax: +33 (0)1 47 56 24 55 Sales Marketing & Communication cardiostim@wanadoo.fr Monique Gauthier Aurore Blitz Phone: +33 (0)1 47 56 21 18 Phone: +33 (0)1 47 56 50 71 Fax.: +33 (0)1 47 56 24 66 aurore.blitz@reedexpo.fr Registration monique.gauthier@reedexpo.fr Marie Le Quellec - Kern Phone: +33 (0)1 47 56 50 84 Congress Registration marie.le-quellec-kern@reedexpo.fr Nathalie Montes Phone: +33 (0)1 47 56 24 83 cdmregistration@ reedexpo.fr1)  ardiostim 2012 and its technical exhibition will be held at Nice C 6) Housing Acropolis Convention Center •  eservation exclusively through Mathez Travel: R 1, Esplanade Kennedy - 06302 Nice Cedex 4 - France www.cardiostimhousing.com Benefit from negotiated rates.2) Lectures, Posters and Video-Clips The congress is holding a large contingentCheck our website www.cardiostim.com of rooms in Nice, but rooms will be assigned on a first-come, first-served basis.Oral presentationsAcceptance: the oral presentations will consist of invited and submitted papers. The Scientific 7) TransportationCommittee will select papers for presentation from the submitted abstracts. All acceptedabstracts will be published in a special issue of an international journal. - by train Book your travel on: www.voyages-sncf.comPosters sessionsAll posters must be submitted in form of abstracts. A number of posters will be selected bythe Scientific Committee for presentation at posters workshops. - by airCAUTION: Portrait display (taller than wide) for all posters, i.e. height 54” in x width 36” in •  any international airlines serve the Nice international airport (www.nice.aeroport.fr). M(1,40 m x 0,90 m). Air Fares discounts Even ID: 12138AFVideo presentations Valid from June 8 2012 to June 21, 2012The presentation must be purely scientific without advertising. Total length of presentation: 15 Even location: Nice, Franceminutes at the maximum. Special viewing room for videotape presentations will be available. Discounts are applied to a wide range of airfares on all Air France and KLM flights worldwide,Accepted standards are: NTSC, Pal and Secam VHS 1/2 sizes, DVD, VCD. if passengers are travelling on the following classes of travel: Espace Affaires (Business) and Economique (Coach).3) Official Language 10% rebate is applied on published non-restrictive public fares.English. A reduction of 5% is granted on restrictive-discounted fares. Use the website of this event or visit to: www.airfranceklm-globalmeetings.com4) Technical Exhibits Keep the document to justify the special fares with you as you may be asked for it at anyThe technical exhibits will be located adjacent to the Conference rooms. point of your journey. To locate your nearest Air France and KLM sales point, visit:5) Luncheon Tickets www.airfrance.comLuncheon tickets are strictly reserved for Cardiostim registrants. Registration is possible on You will need to quote the reference given above which is registered in Air France and KLMour web site: www.cardiostim.com. Price per ticket. Lunch will be served in le Bistrot des data under: GGAIRAFEVENTNEGOMuses located in the Convention Center, Level 3. Check our website www.cardiostim.com Frequent flyer/loyalty programs of Air France and KLM partner airlines are credited with «miles» when Air France or KLM flights are used. •  uring the congress, a free shuttle service to the Congress Center will be available to D registrants staying in Nice at Cardiostim hotels. Information on www.cardiostim.com62 www.cardiostim.com
    • Lumax 740 with ProMRI®World’s firstICD series approved for MRINEW Lumax 740 ICD series with ProMRI® BIOTRONIK’s breakthrough innovation delivers the world’s first ICD series providing patients access to MRI. Solutions for today – innovations for tomorrow www.biotronik.com / promri